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ABSTRACT 
 
The study aim was to identify associations between deficits in specific cognitive domains and 
gait performance in Mild Cognitive Impairment (MCI). Sixty-eight participants with MCI 
underwent cognitive function testing in executive function (EF), attention, working memory, 
episodic memory and language domains. Gait was assessed using an electronic walkway 
(GaitRITE®). The means and co-efficient of variation of five gait parameters were evaluated: 
velocity, stride time, stride length, step width and double support time during single (SG) and 
dual-task (DT) test conditions. Multivariable linear regression analysis demonstrated deficits 
in EF, working memory and episodic memory were significantly associated with increased 
gait variability (GV) under both walking test conditions. DT gait revealed additional 
significant associations between deficits in attention and language domains and increased 
GV.  Deficits in multiple cognitive domains such a language, working and episodic memory 
are associated with increases in GV.  The associations also suggest gait control shares similar 
neural networks as memory and language.  
 
Keywords: gait, gait variability, aging, dual-task, cognitive function, mild cognitive impairment  
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Chapter 1: LITERATURE REVIEW 
1.1 Introduction 
 
Within Canada’s aging population, recent estimates suggest an overwhelmingly 
rapid increase in the proportion of people aged 65 and older (Fries, 2002). This steady 
increase will be accompanied by considerable amounts of disability and dependency 
impacting quality of life and everyday functioning of older adults (van Iersel, Kessels, 
Bloem, Verbeek & Rikkert, 2008). Cognitive and gait impairments are common geriatric 
syndromes which often coincide in an older adult. Gait impairments have been associated 
with an increased risk for falls and functional decline (Callisaya, Blizzard, McGinley, 
Schmidt & Srikanth, 2010; Hausdorff, Rios & Edelberg, 2001; Maki, 1997; Sudarsky, 
2001; Tinetti, Speechley & Ginter, 1988). In addition, gait impairments have also been 
found to be a risk factor for the development of mild cognitive impairment (MCI) and 
further progressive cognitive decline (Buracchio, Dodge, Howieson, Wasserman & Kaye, 
2010; Mielke et al., 2013; Verghese, Wang, Lipton, Holtzer & Xue, 2007; Verghese et 
al., 2002).  A decline in cognitive abilities, specifically executive function (EF), has been 
recognized as another independent risk factor for falls and serious fall-related injuries in 
the elderly (Herman, Mierlman, Giladi, Schweiger & Hausdorff, 2010; Holtzer et al., 
2007; Muir, Gopaul & Montero-Odasso, 2012; Springer et al, 2006; van Iersel et al., 
2008; Yogev- Seligmann, Hausdorff & Giladi, 2008). In fact, those with moderate to 
severe cognitive impairments are twice as likely to experience a fall compared to 
cognitively intact older adults (Montero-Odasso, Muir & Speechley, 2012; Sheridan & 
Hausdorff, 2007; Tinetti et al., 1988).  Given the evidence supporting these associations 
and the demographic change in the proportion of adults over age 65, it is not surprising 
that the relationship between cognitive impairment and gait dysfunction has received 
increasing attention over the past decade.  
 
Gait and balance have traditionally been perceived as automatic, biomechanical 
processes and falls were considered an outcome due to the failure of these motor control 
mechanisms (Segev- Jacubovski et al., 2011). Age- related declines in physiological 
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systems such as cardiovascular, musculoskeletal, visual, vestibular and proprioception are 
viewed as key elements related to detrimental changes in gait and balance. With 
advancing age, the control of gait becomes more difficult because it is less automatic and 
requires more attention (Woollacott & Shumway-Cook, 2002). In the past, cognitive and 
mobility impairments have been treated as separate geriatric syndromes which may have 
led to gaps in the literature preventing our understanding of cognitive and motor 
interactions (Montero-Odasso, Verghese, Beauchet & Hausdorff, 2012). However, over 
the past decade evidence has emerged for a pathophysiological interaction between gait 
and cognitive function, suggesting decreases in attentional capacity that can accompany 
aging highlights the cortical and sub-cortical involvement of gait control (Alexander, 
1996; Hausdorff, Yogev-Seligmann, Springer, Simon & Giladi, 2005; Sheridan & 
Hausdorff, 2007; Woollacott & Shumway-Cook, 2002). Despite recent developments, the 
mechanisms by which cognitive impairment affects gait performance or the temporal 
relationship between the two are not fully understood (Amboni, Barone & Hausdorff, 
2013; Montero-Odasso et al., 2012).  Observing an individual while walking and 
performing a secondary task is used as the method to evaluate the cortical control 
regulating gait (Woollacott & Shumway-Cook, 2002). This method of testing is referred 
to as the dual-task (DT) paradigm and is of particular interest because of strong 
associations found between DT gait changes and increased fall risk (Dubost et al., 2006; 
Lundin-Olsson et al., 1997). It has been well established under these test conditions that 
deficits in EF are associated with gait performance, but very few studies have evaluated 
other key cognitive domains such as memory and language or examined the independent 
contribution of  each cognitive domains from each other (Martin et al., 2012).  
 
There is a growing interest in defining early gait abnormalities and 
neuropsychological features that will help identify people who will develop dementia 
(Ambrose et al., 2010; Montero-Odasso et al. 2012). Recently, there has been an 
expanding area of research investigating gait variability, (measured by the standard 
deviation (SD) or the co-efficient of variation (CoV))  as a measure of cognitive control 
in gait, as well as a marker of cognitive decline and falls in older adults (Dubost et al., 
2006; Montero-Odasso et al., 2011; Verghese et al., 2007).  Gait impairments, defined by 
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increased variability, rarely play a role in early clinical diagnosis of ‘pre-dementia’ (such 
as MCI) subtypes despite evidence to suggest its use as a clinical entity (Scherder et al., 
2007). Studying the relationship between gait and cognition will provide further insight 
to the neural substrates, or structures of the brain underlying gait control in aging and 
help provide targets for therapeutic interventions that have the potential to prevent both 
mobility and cognitive decline (Brach, Perera, Studenski & Newman, 2008; Martin et al., 
2012; Montero-Odasso et al., 2012).  
 
The goal of this study was to: 1) evaluate the association between gait and 
cognition using gait analysis that allows the for analysis of a wide range of gait 
parameters and 2) to demonstrate that the evaluation of specific cognitive domains and 
gait in the earliest stages of pre-dementia can reveal relationships between gait 
impairments and cognitive decline.  
 
1.2 Gait and Mobility  
 
The term gait is widely used within the rehabilitation field to describe human 
ambulation. Gait requires two functional abilities of equilibrium and locomotion. 
Equilibrium is the ability to maintain upright posture and balance, whereas locomotion is 
the ability to initiate and maintain dynamic rhythmic stepping (Nutt, Marsdon & 
Thompson, 1993). Gait is considered the most important expression of mobility 
capability (Hausdorff & Alexander, 2005).  Mobility, defined as the ability to 
independently and safely navigate in one’s environment, is a facet of gait and an essential 
feature of functional independence (Coppin et al., 2006). Goal-oriented locomotion (e.g., 
walking across an uneven surface) in daily life requires the ability to adapt to changes in 
the environment and these adaptations are the result of complex, integrated interactions 
between the central nervous system (CNS), the musculoskeletal system and the 
somatosensory systems (Woollacott & Shumway-Cook, 2002; Trew & Everett, 2005). 
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1.2.1 The Gait Cycle: 
 
The gait cycle (Figure 1.1) describes the actions occurring between the initial 
contact of the heel on the ground to the successive heel strike of the same foot (Kirtley, 
2006; Perry & Burnfield, 2010; Whittle, 2007). A normal gait cycle is divided into two 
phases: stance and swing. Sixty percent of the cycle is comprised of the weight bearing 
stance phase, which occurs when the foot makes initial contact with the ground and ends 
once the same foot is lifted off the ground. The remaining forty percent is comprised of 
the swing phase, which is initiated when the foot leaves the ground and ends when the 
same foot makes contact with the ground, moving the lower limbs in a progressive 
manner (Perry & Burnfield, 2010, Whittle, 2007). 
 
Figure 1.1: Illustration of a normal gait cycle  
 
 
Adapted from Lim M. et al. (2007) 
 
Gait is a complex activity and can be described using terms to identify timing 
components (temporal variables) or distance features (spatial variables). Temporal 
variables of gait include: single limb support time, the period of time during a stride 
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where only one foot is in contact with the ground; double limb support, the period of time 
where both feet are in contact with the ground at the same time (Perry & Burnfield, 
2010); stride time, the time required to complete one full stride. The spatial variables of 
gait include: stride length, the distance between the heel points of two successive foot 
falls of the same foot and consists of two step lengths (Perry & Burnfield, 2010; Whittle, 
2007); step length, the distance measured from the heel of the lead foot to the heel of the 
previous footfall on the opposite foot; step width, the distance between the midpoints of 
the lead foot to the midpoint of the trailing foot (Figure 1.2). Additional terms to 
characterize the features of gait include cadence, the number of steps taken within a given 
time frame and reported as steps per minute, and gait velocity, the distance covered in a 
given time (for example in centimeters per second, cm/sec) (Perry & Burnfield, 2010; 
Whittle, 2007). The combination of cadence and stride length determines gait velocity 
and influences almost all other gait variables (Craik, 1988; Elble et al., 1991) which is 
why they have considerable utility in the quantitative assessment of mobility (Masdeu, 
Sudarsky & Wolfson, 1997; Wolfson, 1990). 
 
Figure 1.2: Spatial gait variables; step length, stride length and step width 
 
Adapted from Wang, F. et al. (2010) 
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1.2.2 Methods of Gait Analysis: 
 
1.2.2.1 Observational Gait Analysis 
 
Observational gait analyses are used regularly in a clinical setting to evaluate gait 
and functional performance to provide information to estimate joint angles, muscle 
activity and some objective gait parameters (Cutlip, Mancinelli, Huber & DiPasquale, 
2000; Whittle, 2007).  These methods include the paper and pencil test (chalking/marking 
subjects soles as they walk on a paper walkway), stop watches and video-based analysis 
(Bilney, Morris & Webster, 2003; McDonough, Batavia, Chen, Kwon, & Ziai, 2001; 
McDonough & Nelson, 1994; Nelson, 1974). Observational methods may appear useful 
in healthy populations, but have poor retest reliability for assessing gait disorders in 
patient populations (Bilney et al., 2002). The simplicity of these methods limit the 
amount of gait information collected, makes them vulnerable to observer error and post 
test data collection can be time consuming (McDonough et al., 2001; Saleh and Murdock, 
1985).  
 
1.2.2.2 Instrumented Gait Analysis: 
 
Three dimensional (3D) motion gait analysis is the most sophisticated method of 
instrumented gait analysis, providing information on kinematic, spatial and temporal gait 
variables (Scholz, 1989). This system uses visual, magnetic or opto-electric systems to 
track limb movement. Markers are placed on a subject’s joint and limb segments and then 
wall-mounted cameras track movement as the person walks past (Perry & Burnfield, 
2010; Scholz, 1989). This method of analysis is highly accurate and detailed in assessing 
gait kinematics, but it is expensive and impractical for clinical and limited for research 
use (Bilney et al., 2003; Cutlip, Mancinelli, Huber & DiPasquale, 2000; McDonough, 
Batavia, Chen, Kwon & Ziai, 2001). 
 
The use of instrumented walkways in a clinical setting has become more common 
(van Uden & Besser, 2004; McDonough et al., 2001). Carpeted electronic mats (e.g. 
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GAITRite
®
) are embedded with pressure-sensitive sensors that capture spatial and 
temporal gait information as a subject walks over the mat (van Uden & Besser, 2004; 
McDonough et al., 2001) (Figure 1.3). Electronic readings of each footfall and 
calculations of different gait parameters are displayed in specialized software on a 
connected personal computer (McDonough et al., 2001). Instrumented walkways have 
excellent test-retest reliability (van Uden & Besser, 2004) and are a valid tool for 
measuring spatial and temporal gait parameters in young, elderly and patient populations 
(Menz, Latt, Tiedemann, Kwan & Lord, 2003). Instrumented walkways provide an 
accurate and quick alternative to objectively observe and diagnose gait disorders, 
eliminating error seen in observational methods. 
 
Figure 1.3:  Simplified schematic of the computerized GAITRite
®
 Walkway  
 
 
Adapted from CIR Systems at http://www.gaitrite.com/downloads/WI-02-
15_Technical_Reference_L.pdf 
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1.3 Gait Velocity 
 
 The propulsion component of gait is illustrated through gait velocity 
(Verghese et al., 2008). Gait velocity as an assessment tool has been reported to be a 
valuable measure for the evaluation of older adults at risk for adverse events (Abellan van 
Kan et al., 2009; Montero-Odasso et al., 2005; Studenski et al., 2003). Maintaining gait 
velocity requires the synchronization of multiple physiological systems, from the 
neurologic and musculoskeletal to cardio-pulmonary and sensory systems (Alexander, 
1996; Montero-Odasso et al., 2005). As one ages, their functional physiological systems 
begin to deteriorate resulting in an inability to maintain gait speed. Therefore, it has been 
proposed that a reduction in gait speed over time could represent an early manifestation 
of pathology in multiple physiological systems and be an early warning sign in 
identifying older adults at higher risk for adverse events (Montero-Odasso et al., 2005; 
Studenski et al., 2003).  
 
1.3.1 Gait Velocity as a Marker of Adverse Events 
 
Physical performance measures like gait velocity are universally accepted for 
assessing functional capabilities in a clinical setting (Ceseari et al., 2005; Montero-
Odasso et al., 2005; Studenski et al., 2003). Gait velocity measurements have proven to 
be a strong indicator of health status and a predictor of adverse health outcomes. In 
healthy older adults, researchers have identified a clinically meaningful cut-off for usual 
gait speed to be 100cm/sec (Bendall, Bassey & Pearson, 1989; Bohannon, 1997; Cesari et 
al., 2005; Imms & Edholm, 1981). Older adults with gait speed below this cut-off value 
should be considered high risk for adverse health outcomes (Cesari et al., 2005). 
Furthermore, Brach et al. (2010) determined a 10cm/sec decrease in velocity to be 
considered a substantial meaningful change. 
 
Individuals with diminished gait speed (less than 100cm/sec) are at an increased 
risk for mobility disability, hospitalizations, institutionalization, falls, and mortality 
(Cesari et al., 2005; Montero- Odasso et al., 2005; Studenski et al., 2003). Gait speed 
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alone was found to be as good an objective predictor of disability (Guralnik et al., 2000), 
hospitalizations and declines in health status as complete physical function performance 
batteries (Studenski et al., 2003). Additionally, several studies suggest motor dysfunction, 
defined by gait velocity slower than 100cm/sec, predicts risk of future onset of dementia 
and Alzheimer’s disease (AD) and progression of further cognitive decline (Camicioli, 
Howieson, Lehan & Kaye, 1997; Holtzer, Verghese, Xue & Lipton, 2006; Kuo et al., 
2007; Waite et al., 2005; Wang, Larson, Bowen & van Belle, 2006). Testing to determine 
gait velocity is relatively easy to administer and does not require any special training of 
the evaluator. These reasons support the recommendation to use gait velocity testing to 
improve clinical and research assessments in identifying older adults at higher risk of 
major health related events (Abellan van Kan et al., 2009). 
 
1.4 Gait Variability 
 
Gait requires and demonstrates complex ongoing adjustments, or variation, in the 
temporo-spatial characteristics, even in predictable environments (Hausdorff, Peng, 
Ladin, Wei & Goldberger. 1995; Hausdorff, 2005; Beauchet et al., 2009). Stride-to-stride 
variability refers to fluctuations within the gait cycle from one stride to the next for any 
spatiotemporal gait characteristics. Historically, variability observed within gait was 
considered external noise which was filtered out of an analysis rather than considered a 
marker of interest (Hausdorff, 2007). 
 
Stride-to-stride variability reflects walking rhythm and is believed to provide 
detailed physiological information in understanding motor control beyond measures 
based on average gait variable values (Hausdorff, 2007). In healthy adults, stride time and 
stride length variability values are generally below 3% (Beauchet, Herrmann, Dubost, & 
Kressig, 2005; Beauchet et al., 2009; Frenkel- Toledo et al., 2005 Montero-Odasso et al., 
2012). Low gait variability reflects the efficiency of the automatic rhythmic stepping 
mechanism (Beauchet et al., 2005; Gabell & Nayak, 1984; Montero-Odasso et al., 2012) 
and the neuromuscular systems’ ability to regulate gait (Hausdorff, 2005; Montero-
Odasso et al., 2012). Though gait variability is a normal feature needed to adapt to 
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changing walking conditions, high gait variability (above 3%) is considered an indicator 
of abnormal gait regulation, an independent predictor of future falls and mobility 
disability (Brach et al., 2001; Hausdorff et al., 2001; Brach et al., 2007; Muir et. al., 
2012). Greater gait variability has also been associated with neurodegenerative diseases 
such as Alzheimer’s disease (AD) (Nakamura, Meguro & Sasaki, 1996; Sheridan, 
Solomont, Kowall & Hausdorff, 2003; Webster, Merory & Wittwer, 2006; Wittwer, 
Webster & Menz, 2010) and Parkinson’s disease (PD) (Frenkel- Toledo et al., 2005; 
Hausdorff et al., 2003; Muir et al., 2012; Schaafsma et al., 2003; Yogev- Seligmann et 
al., 2005). There is also evidence to suggest low step width variability indicates a failure 
to respond to changes in the environment leading to increased fall risk (Gabell & Nayak, 
1984; Brach et al., 2005). Evaluating the magnitude of stride to stride fluctuations offers 
insights into fall risk and mobility function in older adults and a method to quantify 
pathological and age-related changes within the locomotor system (Hausdorff, 2007). 
 
1.4.1 Quantification and Assessment of Gait Variability 
 
Gait variability can be measured using spatial and temporal variables and is 
commonly quantified in the literature using either the standard deviation (SD) or the co-
efficient of variation (CoV) (Brach et al., 2008). The SD reports the magnitude of the 
deviation from mean values (Brach et al., 2008). Unlike the SD, the CoV is independent 
of the units in which variables are collected;  it is calculated as the ratio of the SD to the 
mean, expressed as a percentage (CoV= [(SD/Mean)* 100]) (Brach et al., 2008; 
Hausdorff et al., 2005; Hausdorff, 2005). It is particularly useful for the comparison of 
values with different units or extensively different means (Hausdorff, 2005).  
 
Montero-Odasso et al. (2009) demonstrated in an older adult population, the re-
test reliability of gait variability  was ”excellent” using an electronic walkway under 
usual and dual task walking conditions. Brach et al. (2008) determined a limited number 
of steps (i.e., 5-6) measured using 4m walks had poor reliability for step width, step 
length and stance time variability. However, the use of additional steps (i.e., 10-12) to 
some extent improved the reliability for the gait variability parameters. Inconsistencies 
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across the literature in data instrumentation, distances walked and analytical methods 
reveal controversies in what constitutes optimal protocols for measuring gait variability 
(Lord, Howe, Greenland, Simpson & Rochester, 2011). 
 
1.4.2 Gait Velocity and Gait Variability 
 
Changes observed in stride-to-stride gait variability over a period of time may be 
a more valuable measure in clinical settings to identify at risk older adults compared to 
gait velocity (Verghese at al., 2008; Brach et al., 2007). Many features of gait are highly 
correlated and despite several studies indicating gait speed influences gait variability 
(Beauchet et al., 2009; Belli et al., 1995; Dubost, 2006; Heiderscheit, 2000), there is 
evidence to suggest gait variability, specifically stride time variability (STV), is 
independent of walking speed (Brach et al., 2007; Danion, Varraine, Bonnard & 
Pailhous, 2003; Frenkel- Toledo et al., 2005; Grabiner, Briswas & Grabiner, 2001; 
Hausdorff et al., 2003; Maki, 1997). 
 
As mentioned, gait velocity has been shown to influence gait variability. 
Increased STV was found as walking speed was systematically increased or decreased 
beyond comfortable walking pace (Van Emmerik, Wagenaar, Winogrodzka & Wolters, 
1999). Thus, a U-shaped relationship between STV and gait velocity was then suggested, 
where higher STV was observed in very slow or fast speeds (Heiderscheit, 2000). 
Furthermore, Belli et al. (1995) reported a significant increase in STV as walking speed 
changed from preferred speed to maximum speed. More recently, in healthy young 
adults, Beauchet et al. (2009) demonstrated a curvilinear U-shaped relationship, 
demonstrating STV increased as walking speed decreased (p<0.001) (Figure 1.4). Taken 
together, these results suggest that individuals choose optimal gait speeds for which 
energy consumption and stride time variability are minimal (Belli et al., 1995; Beauchet 
et al., 2009; Danion et al., 2003). 
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Figure 1.4: Curvilinear relationship between stride time variability (CoV) and 
decrease in self-selected walking speed in healthy adults.  Normal self-selected 
walking speed used as the reference level and coded as 0 cm/sec.  
 
 
Copyright © BioMed Central from Beauchet O. et al. (2008) 
 
 
Several studies suggest gait variability is a reflection of the central neuromuscular 
control systems ability to regulate gait and an increase is not necessarily a by-product of 
slow gait (Hausdorff, 2004). This idea suggests gait variability as an entirely influenced 
by gait speed should be disregarded. Age-related changes in gait variability were found 
even when walking speed was held constant (Danion et al., 2003; Kang & Dingwell, 
2007) and a study observing older adults with and without a history of falls found no 
differences in gait speed, but those who fell had significant increases in gait variability 
(p<0.001) (Hausdorff, Edelberg, Mitchell, Goldberger & Wei, 1997). Maki (1997) 
demonstrated in older adults that gait variability was related to fall risk while walking 
speed was related to fear of falling. Furthermore, Frenkel- Toledo et al. (2005) were 
among the first to identify swing time variability as an independent parameter from gait 
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speed. Additionally, Brach et al. (2007) found stance time variability, when controlled for 
gait speed, to be independently associated with future mobility disability. In a study of 
AD patients, stride time variability was found to be significantly increased (p<0.001), 
even though they walked at similar speeds as healthy controls (Webster et al., 2006).  
 
In summary, although a relationship between gait speed and variability is evident, 
velocity cannot be solely responsible for stride to stride fluctuations (Frenkel- Toledo et 
al., 2005). Gait variability appears to be affected during extreme walking speeds, while 
during self selected usual pace, variability is minimized. Overall, evidence suggests gait 
variability may be a more sensitive marker compared to gait velocity of gait control and 
stability (Hausdorff, Edelberg, Mitchell, Goldberger & Wei, 1997; Hausdorff, Schweiger, 
Herman, Yogev-Seligmann & Giladi, 2008), an indicator of underlying pathologies 
(Gabell & Nayak, 1984) and a better determinant of fall risk in an older adult population 
(Hausdorff et al., 2001; Maki, 1997; Verghese et al., 2009). 
 
1.4.3 Gait Variability as a Marker of Adverse Events 
 
Stride to stride fluctuations have increasingly become a common area of research 
as it provides a window for the study of locomotor control (Hausdorff, 2007; Montero-
Odasso et al., 2012). An increase in variability may be caused by changes in a number of 
physiological factors related to aging or underlying disease, such as neuromuscular 
control, peripheral systems, musculoskeletal function and postural control. Additionally, 
subtle physiological changes can also influence gait variability, including cognitive 
impairments (Figure 1.5). Thus, gait variability can be useful in providing insight into the 
neural control of locomotion. Falls are a common geriatric syndrome with many negative 
consequences (Speechley, 2011; Tinetti, Speechley & Ginter, 1988). Annually, 
approximately 30% of Canadian adults over the age of 65 experience at least one fall. 
Fall survivors often experience soft tissue injuries, restricted mobility and fractures 
(Speechley, 2011; Tinetti, Speechley & Ginter, 1988). It is well established that effective 
strategies for fall prevention and reduction are necessary for high risk older adults 
(Hausdorff, 2007; Tinetti, 1987; Tinetti, Speechley & Ginter, 1988; Speechley, 2011).  
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Figure 1.5: Illustration of the possible underlying mechanisms affecting gait 
variability. (Abbreviations: B.G., Basal Ganglia; B.S., Brainstem; MCI, mild 
cognitive impairment; PD, Parkinson’s Disease; PNS, Peripheral nervous system). 
 
 
 
Adapted from Rosano, C. et al. (2007) 
 
Current evidence supports gait variability as a useful measure to help identify 
older adults at risk for falls (Callisaya et al., 2011; Hausdorff et al., 2001; Hausdorff, 
2005; Maki, 1987; Owings & Grabiner, 2003; Verghese et al., 2009). Guimaraes & Isaacs 
(1980) were among the first to demonstrate older adults who fell, walked with increased 
gait variability (step time and step length) compared to non-falling older adults. Maki 
(1997) showed among older adults that a decreased step width variability and an 
increased step width prospectively discriminated individuals who fell from those who did 
not. It was also found that gait speed was related only to fear of falling and not to the 
actual risk of falling, while gait variability measures predicted future falls. Furthermore, 
although gait speed, mental status and ability to perform activities of daily living (ADLs) 
were similar between fallers and non-fallers in this community-dwelling older adult 
population, increased stride time variability was associated with an increased risk for 
future falls (Hausdorff et al., 2001) (Figure 1.6). Among patients with AD, significant 
associations between increased stride length variability and falls were found and it was 
suggested to be the best predictor of falls in this population (Nakamura et al., 1996; 
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Sheridan & Hausdorff, 2007).  These results were confirmed by Verghese et al. (2009) in 
an elderly population, where fall risk was predicted by increased swing time and step 
length variability. Taken together, these studies demonstrate that the magnitude of 
variability in several gait parameters may be more closely related to fall risk when 
compared to conventional measures of averages of gait speed. The studies also highlight 
the clinical utility of gait variability in quantitative gait assessments for the evaluation of 
mobility and fall risk in the elderly. 
 
Figure 1.6: Stride-to-stride fluctuations in stride time measured at baseline, in an 
elderly subject who subsequently fell during the 1 year follow-up period and an 
elderly subject who did not fall.  
 
 
 
Copyright © Archives of Physical Medicine and Rehabilitation from Hausdorff, J. et al. 
(2001)  
 
1.4.4 Neural Control of Gait and Gait Variability 
 
 Many physiological systems are involved in gait regulation. The following 
section will describe and highlight important brain structures and neural systems required 
for locomotion. 
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1.4.4.1 Neural Control of Gait 
 
Human locomotion and many other movements are achieved through complex, 
hierarchical processes in the central nervous system (CNS) (Nakazawa, Obata & 
Sasagawa, 2012; Fukuyama et al., 1997). The highest level of control for motor function 
within the CNS (brain and spinal cord) is the cerebral cortex, basal ganglia and the 
cerebellum (Fukuyama et al., 1997; Takakusaki, Nozomi & Masafumi, 2008). The 
cerebral cortex is divided into four lobes: frontal, parietal, temporal and occipital (Trew 
& Everett, 2005; Widmaier, Raff & Strong, 2006) (Figure 1.7).  The cerebral cortex 
performs the most complex information integration and is responsible for higher 
cognitive functions such as planning, attention, memory storage and perception (Trew & 
Everett, 2005; Widmaier, Raff & Strong, 2006).  Different lobes are responsible for gait 
at different stages, but the exact role of each lobe in human gait remains unknown 
(Fukuyama, et al., 1997; Nakazawa et al., 2012).  
 
Figure 1.7: Four separate lobes of the brain 
 
 
Adapted from Widmaier, E. et al. (2006).  
 
The cerebral cortex, specifically the supplementary motor area (SMA) and the 
basal ganglia (a sub-cortical structure) initiate locomotion and integrate information from 
all somatosensory, visual and motor areas of the brain to allow for the planning, 
execution and coordination of voluntary movements. Located in the posterior portion of 
the frontal lobe, the primary motor cortex is responsible for integrating afferent brain 
information and sending the final global motor command via fibre connections to the 
Occipital lobe 
Cerebellum 
Frontal Lobe  Parietal Lobe 
Temporal Lobe  
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brainstem and spinal cord (Graziano, Taylor, Moore & Cook, 2002; Takakusaki et al., 
2008; Trew & Everett, 2005).  
 
A neural pathway called the cortical-basal ganglia-thalamocortical loop provides 
connections for communication between the cerebral cortex, the basal ganglia, thalamus, 
cerebellum and the brainstem (Figure 1.8). The current understanding of the loop is that it 
is necessary for accurate control of voluntary movements requiring intention, cognition 
and attention (Elble, 2007; Middleton & Strick, 2000; Takakusaki et al., 2008). The 
primary role of the brainstem in motor function is to initiate contractions of postural 
muscles to maintain body posture and balance during changing environmental 
 
Figure 1.8: Schematic representing the cortical-basal ganglia-thalamocortical loop 
in the control of voluntary movements, locomoton and muscle tone. (Abbreviations: 
MLR, midbrain locomotor region; PPN, pedunculopontine nucleus) 
 
 
Copyright © The Journal of Neurology from Takakusaki, K. et al. (2008) 
 
circumstances (Elble, 2007; Takakusaki et al., 2008; Trew & Everett, 2005).  The 
pedunculopontine nucleus (PPN) is a brainstem structure which plays a central role in 
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neural communication important for movement between the higher level control centers 
in the brain and the spinal (Elble, 2007; Mena-Segovia, Bolam & Magill, 2004; 
Takakusaki et al., 2008). The PPN is highly interconnected with the basal ganglia and 
together they are responsible for the automatic regulation of postural muscle tone, the 
execution of rhythmic limb movements and inhibition of unwanted movements (Mink, 
2003; Takakusaki et al., 2008).  
 
The spinal cord’s crucial role in human movement is to act as a relay system 
transmitting neural signals between the brain and the rest of the body. It also contains 
neural circuits which control reflexes and central pattern generators (CPGs) (Dietz, 2003; 
Nakazawa et al., 2012; Trew & Everett, 2005).  Central pattern generators (CPGs) are 
neural networks between the brainstem and the spinal cord (Dietz, 2003; Duysens & Van 
de Crommert, 1998; Trew & Everett, 2005). CPGs are described as complex neuronal 
networks within the spinal cord that can generate self-sustained rhythmic motor patterns 
that drive movements, even in the absence of input from higher level brain centers (Dietz, 
2003; Nakazawa et al., 2012). Even though it is generally accepted that CPGs are 
responsible for locomotion in mammals, the underlying principles of CPGs function are 
based on results in experimental animals models and the role of CPGs do not translate 
directly to our understanding of human locomotion (Dietz, 2003; Fukuyama et al., 1997; 
Nakazawa et al., 2012).  
 
Classical research experiments completed by Brown in 1911 and 1912 
demonstrated cats with a transected spinal cord, causing deprivation of supraspinal and 
proprioceptive input, were still able to initiate and display complex rhythmic motor 
output. These results suggested that higher level cortical processing was unnecessary 
during automatic locomotion execution. (Dietz, 2003; Duysens & Van de Crommert, 
1998; Nakazawa et al., 2012; Takakusai et al., 2008). In humans, current evidence 
suggests sufficient muscular force cannot be generated from subcortical neural networks 
alone to sustain stepping patterns of a gait cycle (Nakazawa et al., 2012). The current 
understanding of CPGs in human locomotion is that they likely receive information from 
higher level cortical control centers as well as sensory afferents from visual, auditory, 
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vestibular and proprioceptive receptors (McCrea & Rybak, 2008; Rossignol, Dubuc & 
Gossard, 2006; Saint-Cyr, Taylor & Nicholson, 1995). Human locomotion is more 
unstable and additional descending cortical control is most likely required (Takakusai et 
al., 2008).  
 
The cerebellum is essential for movement coordination. It utilizes feedback 
circuits to integrate ‘real time’ input signals from visual, auditory, vestibular and 
somatosensory cortices to perform smooth, correct and synchronized motor actions 
(Takakusaki et al., 2008; Trew & Everett, 2005. The cerebellum also works closely with 
the brain stem to regulate aspects of posture control and maintain equilibrium of limb 
movements during locomotion (Takakusaki et al., 2008; Widmaier, Raff & Strong 2006).  
 
In summary, gait is a highly complex task which depends on both automatic and 
intentional processes. The basal ganglia and structures within the brain stem are required 
for the automatic regulation of gait, where adaptive functional gait navigation depends on 
higher level cortical control centers. Failure in the ability of these systems to 
communicate effectively results in motor dysfunction and gait impairments.  
 
1.4.4.2 Neural Control of Gait Variability 
 
Little is known about the mechanisms underlying the stride-to-stride fluctuations 
quantified in gait variability (Brach et al., 2007; Hausdorff, 2005). In a healthy locomotor 
system, inputs from the basal ganglia, cerebral cortex and cerebellum, in combination 
with feedback from the vestibular, visual and proprioceptive systems are integrated to 
generate limb movements that are smooth, accurate and coordinated. Subsequently, the 
output of this integration is expressed through spatial and temporal gait parameters 
(Hausdorff et al., 2008). Evidence suggests each gait variable may be regulated by 
different physiological mechanisms and raises the importance of investigating the 
parameters separately in an attempt to understand the organization and regulation of gait 
control (Hausdorff, 2007). 
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Early work by Gabell & Nayak (1984) proposed variability in step length and 
stride time were representative of the rhythmic, automatic stepping mechanisms brought 
about by repeated sequential contractions and relaxation of muscle firings producing 
forward propulsion. Through studies of neurological diseases and their associations with 
increased gait variability, it was suggested that these characteristics are more dependent 
on central neural control and cognition than musculoskeletal performance (Beauchet et 
al., 2005; Montero-Odasso et al., 2012). In humans, the PPN forms part of the rhythmic 
locomotor center which has direct projections to the spinal cord (Mena-Segovia et al., 
2004; Takakusaki et al., 2008), suggesting it may have a role in the control of CPGs 
(Jahn et al., 2008). With that said, we can conclude that the magnitude of stride time and 
stride length variability are controlled largely in part by the brainstem and basal ganglia 
in addition to frontal and prefrontal cortices (Brach, Studenski, Perera, VanSwearingen & 
Newman, 2007; Hausdorff, 2008).  
 
Variability in the gait parameters, of step width and double support time are 
predominately determined by balance control mechanisms (Gabell & Nayak, 1984). 
These variables are more closely associated with sensorimotor functions such as 
muscular strength (Callisaya et al., 2010). A disruption in balance control would result in 
an increase in step width and double support time variability indicating a lack of 
compensation for instability (Brach et al., 2007; Gabell & Nayak, 1984). However, recent 
evidence suggests older adults who walk with extreme step width variability (either high 
or low) are at increased risk for falls and has led to inconsistencies in published 
normative values for these parameters (Brach et al., 2005). The control or generation of 
gait variability is likely multi-factorial and a thorough understanding of the underlying 
mechanisms of each gait parameter will help explain locomotor functions and factors 
which can be modified in therapeutic interventions for gait impairments. 
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1.5 Cognition 
 
Cognition is not an easily definable term as it can be interpreted differently 
depending on an individual’s background or area of study (Benjafield, 2007). For the 
purpose of this study, it is simply defined as the mental processes involved in the 
acquisition, storage, transformation and use of knowledge (Matlin, 1998).  The countless 
pathways of obtaining knowledge is why cognition is associated with several other 
concepts including awareness, comprehension, intelligence, recognition, skill and 
understanding, all of which are involved at some level to one or more cognitive domains 
(Matlin, 1998). 
 
1.5.1 Cognitive Domains 
 
 The unique and distinct characteristics of each specific cognitive domain will 
be highlighted here. These domains are outlined based on various hypotheses suggesting 
their role on gait and mobility. It is important to understand that these terms are not 
distinct independent features and some overlaps exist between domains.  
 
1.5.1.1 Executive Function 
 
Executive function (EF) refers to a set of higher level cognitive functions, 
working collectively to modify cortical sensory input to produce behaviour required for 
regulation of goal directed movements (Sheridan et al., 2003; Yogev-Seligmann et al., 
2008). EF is also involved in the control of attention and aspects of working memory 
resources (Yogev- Seligmann et al., 2008; Sheridan & Hausdorff, 2007). The functions of 
EF include initiation or intention of action, planning, problem solving, action monitoring 
and attention (Lezak, 1995; Sheridan & Hausdorff, 2007; Yogev-Seligmann et al., 2008). 
The frontal and prefrontal lobes, predominately the dorso-lateral prefrontal cortex and the 
anterior cingulate cortex, have been related to the cognitive features of EF (Yogev-
Seligmann et al., 2008).  However, there is evidence to suggest EF activates other areas 
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of the brain and are not only localized to the frontal cortex (Collette, Hogges, Salmon & 
Van der, 2006; Lorenz-Reuter, 2000; Stuss & Levine, 2002). 
 
1.5.1.2 Attention 
 
Attention is often considered a specific example of EF. The term describes 
different processes driven by sensory perception that are related to how an organism 
becomes receptive to stimuli and how it overlooks or begins to process incoming internal 
or external excitation (Lezak, 1995; Sheridan et al., 2003; Yogev-Seligmann et al., 2008). 
Attention can be further subdivided into three types: selective, sustained and divided. 
Selective attention refers to the filtering of irrelevant stimulation and suppression of 
distracters (Lezak, 1995). Sustained attention is the ability to maintain attention on a task 
for a period of time. Lastly, divided attention is the ability to perform multiple tasks at the 
same time, shifting attention from one task to the other (Lezak, 1995). This type of 
attention not only plays an important role in complex challenging environments but is 
also important, to a lesser degree, in routine walking environments (Yogev-Seligmann et 
al., 2008). Similar to EF, attention is associated with the prefrontal cortex, primarily the 
dorsolateral prefrontal cortex and the anterior cingulate gyrus. Evidence also suggests 
aspects of attention are associated with the parietal lobe (Perry & Hodges, 1999). 
 
1.5.1.3 Memory 
 
Working memory refers to a set of linked information processing systems 
necessary to maintain or retrieve newly acquired information for short term storage and 
manipulation while a subject is engaged in complex cognitive tasks (Baddeley, 1992). 
Early work suggested working memory was associated with hippocampal systems (Olton, 
Becker & Handelman, 1979) but were based on single cell non-human animal models. 
Follow-up studies in humans indicated that areas typically associated with language 
processing (Broca’s area) and the posterior parietal cortex were also associated with 
working memory (Baddeley & Hitch, 1974; Markowitsch et al., 1999; Shallice & Vallar, 
1999; Vallar, Betta & Silveri, 1997). However, the most recent evidence credits the 
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dorso-lateral and ventro-lateral regions of the prefrontal cortex with the central role in 
working memory (D’Esposito, Postle & Rypma, 2000; D’Esposito, 2007; Müller & 
Knight, 2006). 
 
Episodic memory is one of the two distinct features of declarative memory and 
refers to a long term memory network, which is unique because it is oriented in the past 
and accompanied by the conscious capability to store, recollect and re-experience 
personal past events in the context of space and time (Tulving, 1972). Declarative 
memory refers to memories which can be consciously stored and recalled such facts, 
events or knowledge (Tulving, 1972). Functional neuro-imagining studies indicate 
episodic memory is primarily supported by neural connections in the medial temporal 
lobe, predominately the hippocampus, which also interacts with other cortical areas 
(Fletcher, Frith & Rugg, 1997; Nyberg, 1997; Squire et al., 1992). Evidence has also 
found cortical activation in the prefrontal cortex and superior parietal lobe activation 
during encoding and retrieval aspects of episodic memory (Buckner et al., 1995; Buckner 
& Tulving, 1995; Kapur et al., 1995; Schacter, Wagner & Buckner, 2000), which is for 
active management and monitoring of episodic memory (Fletcher et al., 1997).  
 
 Semantic memory is the second distinct feature of declarative memory and is 
comprised of knowledge of facts, vocabulary and concepts learned through everyday 
experiences independent of personal experiences (Tulving, 1972; Tulving 1991). 
Through various neuro-imaging studies, the inferior temporal lobe and pre-frontal cortex 
are the two regions which tend to be consistently activated during semantic memory tasks 
(Martin, Haxby, Lalonde, Wiggs & Ungerleider, 1995; Martin, Wiggs, Ungerleider & 
Haxby, 1996; Vandenberghe, Price, Wise, Josephs & Frackowiak, 1996). 
 
1.5.1.4 Language 
 
Language refers to a structured system of communication which uses written or 
spoken words and symbols to explain the external environment or personal thoughts 
(Price, 2000). The language domain consists of categories related to speech expression, 
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auditory comprehension, naming, reading and writing (Price, 2000; Strauss, Sherman & 
Spreen, 2006). Aphasia is a general term used to describe deficits in language 
comprehension and expression (Damasio & Geschwind; 1984). Broca’s area and 
Wernicke’s area communicate extensively between each other and are usually located on 
the left in frontal and temporal lobes respectively. These areas also share neural 
connections to the motor cortex which generates speech (Price, 2000).  Traditionally, 
Broca’s area is associated with correct speech production and articulation, whereas 
Wernicke’s area is associated with language comprehension and processing (Obler et al., 
2010; Friederici, 2002; Vigneau et al., 2006).   
 
Figure 1.9: Lateral left hemisphere view of the brain and areas associated with 
language and speech production. (Abbreviations: P.A.C., primary auditory cortex) 
 
Adapted from Price, C. (2000). 
 
1.6 Identifying Individual Cognitive Domain Contribution on Gait  
 
Many of the cortical and sub-cortical regions involved in higher level 
cognitive functions discussed above, overlap with areas involved in motor control. 
However, the act of walking alone cannot be used to evaluate the relationship between 
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individual cognitive domains and gait. Methods for isolating cognitive components from 
musculoskeletal components of gait and going beyond observing discrete pathology (i.e. 
brain lesions) are needed. This section will describe the technique, the dual task 
paradigm, used to evaluate how functions of the individual cognitive domains influence 
gait performance.  Studies in both healthy and cognitively impaired adults confirm such a 
relationship by demonstrating dual-task (DT) effects on gait and associations between 
cognitive deficits and gait dysfunction 
 
1.6.1 Evaluating Cognitive Control on Gait: Theories of Dual Task (DT) 
Interference 
 
Performing two tasks simultaneously can result in detrimental effects on one or 
both tasks. The “outcome conflict” where one tasks produces output which prevents the 
processing of another task is referred to as DT interference (Navon & Miller, 1987; 
Pashler, 1994).The underlying mechanisms of DT interference provide pertinent details 
on the functional structure of the brain and help explain an individual’s ability or inability 
to simultaneously manage multiple tasks in different environmental situations (Pashler, 
1994). Explanations of DT interference generally revolve around three theoretical 
approaches. 
 
The first model, the bottle neck theory, proposes processing systems are only 
capable of handling input from one task at any given time. Under these circumstances, 
when two tasks are presented concurrently and require the same neural networks, they 
both compete for resources resulting in a delayed or impaired response in one or both 
tasks (Pashler, 1994; Tombu & Jolicoeur, 2003). The second model, the cross-talk model 
suggests interference is caused not by the capacity of the information processing systems, 
but by the type of input presented and the consequent responses (Pashler, 1994). This 
model posits two tasks from similar cognitive domains recruit the same neural networks 
allowing easier performance of both tasks concurrently. Conversely, it becomes difficult 
to perform the two tasks if they are from different cognitive domains (Pashler, 1994).  
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The third model and the most widely accepted model of DT interference in gait 
research is the capacity sharing theory. The model is based on the assumption that an 
individual is able to multi-task and can voluntarily allocate attention to the components of 
the combined given task, although the type of task may determine processing priority 
(Pashler, 1994; McLoed, 1977; Tombu & Jolicoeur, 2003). Information processing 
centers are considered to have finite resources that are shared among tasks and processing 
capacity decreases as additional tasks are introduced to the system or as the time between 
stimuli presented is reduced, resulting in a diminished ability to perform one or both 
tasks. (Kahneman, 1973; McLoed, 1977; Navon & Miller, 2002; Tombu & Jolicoeur, 
2003). For example, the performance of additional tasks while walking alters gait 
performance, the secondary task or both (Yogev-Seligmann et al., 2008). Studying the 
DT interference phenomenon has relevant clinical implications as it more closely 
simulates real life situations and begins to explain approaches to practical problems with 
multi-tasking in activities of daily living (ADLs). 
 
1.6.2 Dual-Task Paradigm 
 
The concept of the DT paradigm is based on the capacity sharing theory and 
empirical evidence supports the influence of cognition in gait control (Amboni et al., 
2013; Montero-Odasso et al., 2012). The ‘stops walking while talking’ study was the first 
to demonstrate that an inability to continue a conversation while walking, a DT activity, 
was a marker for future falls in institutional-dwelling older adults (Lundin-Olsson, 
Nyberg & Gustafson, 1997). Since then, observing individuals performing a secondary 
cognitive task while walking is referred to as the DT paradigm and has been used to 
assess the relationships between gait, cognition and risk of falling. How the instructions 
are communicated for performing DT testing influences test performance (Beauchet, 
Dubost, Aminian, Gonthier & Kressig, 2005; Verghese et al., 2007), without explicit cues 
to rank the task the DT paradigm forces the brain to prioritize tasks when no specific 
instructions on prioritization are provided (Amboni et al., 2013). The DT effect on gait 
performance depends on the nature of the secondary task, as the secondary task can be 
cognitive, motor, auditory or visual (Beauchet et al., 2009; Verghese et al., 2007). In 
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general, when challenged under DT conditions, healthy subjects will prioritize 
maintaining gait and posture over a secondary task; this is known as the “posture first” 
strategy (Bloem, Grimbergen, van Dijk & Munneke, 2006). The mean differences 
between gait velocity or variability from a single task to DT indicates the extent of the 
cognitive reserve and is referred to as the “dual-task cost” (Amboni et al, 2011; Montero-
Odasso et al., 2012).  
 
Even though healthy young and older adults alter their gait pattern with decreases 
in gait speed and increased stride-to-stride variability in response to DT, the changes are 
likely to be less detrimental to stability (Beauchet et al., 2005; Dubost et al., 2006; 
Ebersbach, Dimitrijevic & Poewe, 1995; Hausdorff et al., 2008; Verghese et al., 2007). In 
a study of healthy young adults, DT gait speed decreased from 130cm/sec to 123 cm/sec 
(5% change) and the CoV of stride time increased from 1.8% to 2.1% (0.3% change). 
Even though the change leaves their gait velocity well above the “normal” threshold for 
these parameters, the literature does not definitively state whether it is the magnitude of 
change or decreases below a certain threshold which indicate reduced attentional 
capacities. Additionally, greater DT costs in gait are seen in older adults with history of 
falls (Beauchet et al., 2009; Hausdorff et al., 2008) and in individuals with cognitive 
impairments (i.e. MCI, AD). Moreover, it was also determined that as the severity of 
cognitive impairment or DT complexity increases, gait performance measures worsen 
(Figure 1.10). (Camicioli et al., 1997; Montero- Odasso et al., 2012; Muir et al., 2012; 
Sheridan et al., 2003).  
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Figure 1.10: The effect of complex dual task conditions (serial 7 subtractions) in 
stride time in an older adult with normal cognition (A) compared to an older adult 
with mild cognitive impairment (B). 
 
 
Copyright © Archives of Physical Medicine and Rehabilitation from Montero-Odasso M. 
et al. (2012) 
 
1.6.3 Evidence Supporting the Relationship between Gait and Cognition 
 
Recently many studies have examined the complex relationship between specific 
cognitive functions and gait performance with use of the DT paradigm. In their study of 
non-demented older adults, Hausdorff and colleagues (2005) were among the first to 
demonstrate that even steady-state walking could be considered a complex task, requiring 
higher level cognitive resources. In the years following, many studies established a 
relationship between gait dysfunction and impairments in EF and attention in healthy 
older adults. These studies consistently show that poorer performance in  EF and 
attentional domains are associated with slower velocity (Ble et al., 2005; Coppin et al, 
2006; Holtzer, Wang & Verghese, 2012; Springer et al., 2006; Watson et al., 2010) and 
increases in gait variability (swing time, step length, stride time and length) (Dubost et 
al., 2006; Hausdorff et al., 2005; Verghese et al., 2007; Verghese et al., 2008; Yogev-
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Seligmann et al., 2008) during DT conditions, not seen during simple motor tasks. These 
results were also replicated in MCI patients (Montero-Odasso et al., 2012; Muir et al., 
2012). Additionally, increased gait variability measures and poor executive function 
during DT conditions was found to predict falls in older adults (Herman et al., 2010; 
Mierlman et al., 2012; Sheridan & Hausdorff, 2007). These results imply intact executive 
function and attention are necessary in older adults to perform complex mobility tasks. 
 
There are inconsistent findings concerning the role of memory in gait control. A 
computerized tomography study showed that a deficit in overall motor performance was 
associated with temporal lobe atrophy (Guo et al., 2001). A few studies have 
demonstrated an association between deficits in episodic and working memory with 
decreased gait velocity in normal aging (Holtzer et al., 2006; Holtzer et al., 2012) and 
MCI (Montero-Odasso et al., 2010).  One study found memory impairment, in addition to 
EF impairments, were associated with greater gait speed decline (Watson et al., 2010). In 
contrast, many studies fail to find an association between memory (working or episodic) 
and gait performance measures (Herman et al., 2010; Martin et al., 2012; van Iersel et al., 
2008), and to date no studies indicate a significant association between memory deficits 
and increases in gait variability (van Iersel et al., 2008). 
 
Evidence is scarce with respect to demonstrating involvement of the language 
domain in gait control. Many studies assessing language function on gait have used a 
factor analysis approach, which likely is not a true independent representation of the 
language domain specifically (Verghese et al., 2008). Using factor analysis, Holtzer et al. 
(2006, 2012) found the language domain was related to gait velocity, but became 
insignificant during DT testing. Additionally they had found deficits in language were not 
related to falls in normal older adults. Conversely, one study which looked at language 
independently, found faster gait speed was associated with less decline in the language 
domain (Mielke et al., 2013).  Currently, no studies indicate a significant association 
between language impairments and increased gait variability. 
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The use of neuro-imaging techniques within this field of research has developed 
over time and they have provided additional support to confirm the cognitive control of 
gait. A Proton Emission Tomography (PET) study demonstrated activation of the 
dorsolateral prefrontal cortex, cingulate cortex, superior and inferior parietal lobes while 
subjects imagined standing, walking and avoiding obstacles (Malouin, Richards, Jackson, 
Dumas & Doyon, 2003).  Magnetic resonance imaging (MRI) studies have assessed the 
role of white matter abnormalities and/ or focal neuronal loss on gait and cognitive 
impairment in older adults (Rosano, Brach, Studenski, Longstreth & Newman, 2007; 
Rosano et al., 2008). Gait variables and their respective variability values were 
independently associated with subclinical brain infarcts, white matter abnormalities and  
focal neuronal loss in regions related to motor, attention and executive control (Rosano et 
al., 2007; Rosano et al., 2008). Rosano and colleagues (2008) also found that diminished 
volumes in the sensorimotor (motor) and fronto-parietal (cognitive) regions were 
associated with reduced stride length and increased double support time. In a subsequent 
study, a smaller prefrontal area was related to slower gait and processing speed, 
suggesting shared neural basis for both functions (Rosano et al., 2012). Furthermore, a 
study of neuro-chemical and functional changes in a cognitively intact elderly population 
found reduced stride length was associated with smaller hippocampal volume and 
decreased hippocampal metabolism was associated with increased stride length 
variability (Zimmerman, Lipton, Pan, Hetherington & Verghese, 2009).  Taken together, 
these findings refute complete locomotor automaticity and suggest higher level cognitive 
contribution is involved in regulation of gait speed and variability. 
 
1.7 Mild Cognitive Impairment (MCI) 
 
Recent investigations have identified MCI as a transitional stage between normal 
cognitive functioning and dementia. MCI is a relatively new concept and despite 
extensive supporting evidence of the syndromethere are contentious debates on defining 
MCI, its clinical significance, prevalence, and determining the appropriate guidelines for 
diagnosis (Albert & Blacker, 2006; Larrieu et al., 2002; Ritchie, 2004; Gauthier et al., 
2006).  MCI is a controversial concept and is now the focus of natural history, biomarker 
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and AD prevention studies in an attempt to identify the earliest stages of cognitive 
decline (Chertkow, 2002). Many aging adults are likely to develop cognitive 
impairments, but not all cases will develop into dementia. 
 
1.7.1 Characteristics of Mild Cognitive Impairment 
 
With age cognitive function can remain stable, decline gradually over time to a 
state of MCI, or further progress to dementia (Feldman & Jancova, 2005). Fundamental 
work by Petersen et al. (1999) developed the foundations for MCI classification. They 
determined MCI patients could be differentiated from cognitively normal and those with 
mild Alzheimer’s disease. Petersen’s initial criteria only included deficits inconsistent 
with one’s age within the memory domain. Subsequently, Winblad et al. (2004) revised 
and established a more recent criteria for MCI diagnosis incorporating additional 
domains of cognition beyond memory. Petersen then revised his initial criteria to be more 
consistent with the consensus criteria by Winblad and colleagues (2004). The current 
criteria identifies a period in time when an individual’s cognitive decline is greater than 
expected at a given age and education level (>1.5 standard deviations below normal on 
tests of cognitive function), but the change does not meet the criteria for dementia. These 
individuals have consistent memory complaints, usually verified by a close informant and 
reinforced by objective validated cognitive and neuropsychological assessments. MCI 
patients will display evidence of cognitive decline over time while maintaining the ability 
to perform ADLs (Petersen et al., 1999; Petersen et al., 2001; Petersen, 2004 Winblad et 
al., 2004). 
 
There are inconsistencies regarding the prevalence of MCI due to the recent 
classification of the term (Albert & Blacker, 2006), discrepancies in the 
operationalization of subtypes (Ward, Arrighi, Michels & Cedarbaum, 2012), differing 
diagnostic measures (Petersen et al., 1999) and the differences between population and 
clinic-referred study samples (Feldman & Jancova, 2005). The prevalence in clinic-
referred samples is assumed to be greater than the general population of older adults. 
Based on a recent systematic review in North America, the prevalence for MCI in older 
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adults over the age of 65 varies and is estimated to range anywhere between 20% and 
26% (Ward et al., 2012), increasing to 29% in older adults over 85 years old (Lopez et 
al., 2003). Studies estimate 10– 15% of older adults with MCI progress to dementia 
annually (DeCarli, 2003; Petersen et al., 1999; Petersen, 2004), whereas older adults 
without MCI develop dementia at a rate of 1-2% annually (Petersen et al., 1999). 
 
Individuals with MCI are at an increased risk for mobility impairment and further 
cognitive decline (Bennett et al., 2002; Liu-Ambrose et al., 2008; Verghese et al., 2008). 
As a result, greater focus has been directed to the early identification of patients at high 
risk for cognitive decline and to interventions at the earliest stages of ‘pre-dementia’ such 
as MCI (Albert & Blacker, 2006; Burns & Zaudig, 2002; Thompson & Hodges, 2002). 
MCI likely represents a stage within the neurodegenerative disease process of dementia 
which may respond to treatment to alter disease trajectory and the severity of the 
impairment is subtle enough to allow a higher threshold of cognitive testing in order to 
uncover the influences of different cognitive domains on gait performance (Montero-
Odasso et al., 2009).  
 
1.7.2 Heterogeneity of Mild Cognitive Impairment  
 
It is unknown whether every MCI case can be considered a prodrome for 
neurodegenerative diseases, such as AD, as not all people diagnosed with MCI will 
progress to dementia.  Approximately 40% of MCI cases will remain stable over time 
(i.e., their cognitive status neither gets better or worse) (Burns & Zaudig, 2002; Ritchie, 
2004; Ganguli, Dodge, Shen, & DeKosky, 2004). Heterogeneity within this population 
likely contributes to the variation of clinical outcomes and underlying physiological 
pathology that can develop over time, such as functional impairments, AD and other 
types of dementia (Albert & Blacker, 2006). MCI has been divided into two different 
subtypes: amnestic and non-amnestic (Petersen, 2004). Amnestic MCI (aMCI) is the 
most common and it is often thought of as a precursor to AD (Ghosh, Libon & Lippa, 
2013; Petersen, 2004).These patients have subjective memory complaints (usually 
episodic memory) which is beneficial if corroborated by an informant accompanied by 
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objective memory impairments (Albert & Blacker, 2006; Ghosh et al., 2013; Petersen, 
2004). Those with non-amnestic MCI (naMCI), have impairment(s) in a non-memory 
domain, such as executive function, attention or language (Ghosh et al., 2013; Petersen, 
2004). Due to the relative rarity of a pure MCI subtype, it is likely that most MCI 
samples include a combination of both aMCI and naMCI (Alladi, Arnold, Mitchell, 
Nestor & Hodges, 2006).  
 
1.7.3 Pathophysiology of Mild Cognitive Impairment  
 
There is currently limited evidence to support a pathological process in MCI.  
There are no reported cases of death from MCI; therefore, studies attempting to 
determine a pathophysiology have been conducted post-mortem on individuals with an 
MCI diagnosis who died from unrelated causes (Petersen et al., 2001). These studies 
demonstrated that these patients had an accumulation of disfigured tau proteins within a 
nerve cell, called neurofibrillary tangles, in the hippocampus and entorhinal cortex, which 
is typically viewed as a hallmark of AD histopathology (Du et al., 2001; Petersen, 2001; 
Chertkow at al., 2007; Thompson & Hodges, 2002). Additionally, a neuro-imaging study  
found that individuals with MCI with lower hippocampal volume at baseline were found 
to be more likely to convert to dementia after a 2-4 year follow- up period (Jack et al., 
1999).  
 
In the absence of histopathology studies, neuro-imaging has provided information 
on structural changes of the brain.  A neuro-imaging study by Bennett, Schneider, 
Bienias, Evans & Wilson (2005), found brain changes in individuals with MCI were 
intermediate between normal and AD. These changes were intermediate not only in terms 
of the presence of plaques and tangles (hallmark features of AD), but also in terms of 
cerebral infarcts and Lewy body pathology. Several studies have identified  
apolipoprotein E status as a strong predictor of progression from MCI to AD (Petersen et 
al., 1995; Fleisher et al., 2007), while others have failed to find an association (Aggarwal 
et al., 2005; Devanand et al., 2005). There has been a lot of controversy regarding the 
role of genetic testing in detecting MCI cases that will convert to AD, though a lack of 
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substantial evidence does not support routine genetic screening in patients with MCI 
(Ghosh et al., 2013). 
 
 
1.7.4 Neuropsychological Screening and Diagnosis of Mild Cognitive Impairment 
 
Differentiating symptoms that are attributable to MCI and normal aging can be 
challenging, as forgetfulness and difficulty recalling common names or words are often 
apart of the normal aging process (Ghosh et al., 2013). There is currently no treatment for 
MCI, yet early detection provides an opportunity to introduce therapeutic interventions to 
treat modifiable risk factors that have the potential to alter disease trajectory (Feldman & 
Jacova, 2005). The Mini-Mental State Examination (MMSE), the most widely accepted 
screening tool for dementia, has been found to be insensitive in diagnosing MCI 
(Chertkow, 2007; Petersen, 2004). The MMSE is very general and only successful in 
detecting those with severe cognitive impairment. The Montreal Cognitive Assessment 
(MoCA) is often used to complement the MMSE when screening for MCI. It is a brief 
cognitive screening test proven to have greater sensitivity and specificity to detect MCI 
(Chertkow et al., 2007; Nasreddine et al., 2005). The MoCA differs from the MMSE in 
that it is more difficult and includes a wider range of tests assessing a greater number of 
cognitive functions including executive function, delayed recall, language, attention and 
visuospatial skills. The MoCA also puts less scoring weight on orientation to time and 
place (Nasreddine et al., 2005). There is no generally accepted neuropsychological testing 
battery for MCI, but evidence suggests in order to properly diagnosis MCI testing of 
multiple domains in necessary (Lonie, Tierney & Ebmeier, 2009).  
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1.8 Rationale for Study 
 
 Gait and cognitive impairments will increase as the population ages, exposing 
these older adults to an increased risk to a wide variety of adverse events. Given the fact 
that these two conditions are often coincident in the same individual, it is important to 
completely understand the cognitive factors which may affect and contribute to gait 
control.  Despite growing interest, the exact cortical mechanisms involved in gait control 
are not well known and we lack a thorough understanding of the neural centers that 
regulate gait. Existing literature evaluating the relationship between gait and cognition 
has focused almost exclusively on executive function (EF) and attention, where as the 
role of additional cognitive domains in gait performance remains unknown. Furthermore, 
exisiting studies tend to use very few gait variables or stride-to-stride variability 
characteristics. Increases in gait variability have been proven repeatedly to be associated 
with fall risk in older adults, therefore, discerning cognitive mechanisms of gait 
variability may provide another approach to risk assessment and treatment. Additionally, 
a well-documented limitation in the previous literature has been the lack of integration 
between neuropsychological and gait assessments for identifying older adults at risk for 
cognitive and mobility decline. 
 
 Limited work has been devoted to investigating the interactions between a 
cognitive abilities and gait performance in older adults with mild cognitive impairment 
(MCI). Many of the studies that have examined associations between cognitive function 
and gait control are primarily focused in high functioning populations or patients with 
PD, unfortunately the results cannot be directly extrapolated to MCI populations. MCI is 
a relatively understudied population, especially during DT testing conditions. Individuals 
with MCI provide a patient population which has a higher threshold for tolerance of 
testing allowing the ability to explore the contributions of multiple cognitive domains in 
gait control (Montero-Odasso et al., 2009). Those with MCI also represent a highly 
vulnerable population because they are at an increased risk for falls, mobility decline and 
dementia (Bennett et al., 2002). For these reasons, it is of interest to study a broader range 
of associations in an attempt to understand changes in prodromal entities to AD.   
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 If associations are found between gait performance and individual cognitive 
domains, it will support the idea that gait is controlled by multiple cognitive processes 
beyond EF. The associations would further enhance our understanding of the shared 
neural networks and highlight the benefits of a clinical assessment that includes multiple 
cognitive domains when identifying older adults at high risk for mobility decline. 
 
1.9 Purpose 
 
This investigation evaluated the associations between deficits in several cognitive 
domains (i.e., executive function, attention, language, episodic memory and working 
memory) and quantitative gait variables (temporal, spatial and variability) in people with 
MCI through the use of the DT paradigm. The results will provide evidence to support 
and understand the underlying cognitive processes involved in gait control.  
 
1.10 Hypotheses 
 
It was hypothesized that: 1) performance in quantitative gait variables (spatial, 
temporal and variability) will be associated with deficits in multiple cognitive domains 
beyond EF and that the associations would be greater when a secondary task was added 
to the gait task, 2) gait variability parameters would be able to identify more associations 
in cognitive domains than mean gait variables and 3) stride time variability would show 
the most associations with cognitive domains when compared with other evaluated gait 
parameters of interest and in our sample of older adults with MCI.   
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Chapter 2: METHODOLOGY 
 
2.1 Study Design 
 
This study was a secondary analysis of baseline data collected from three 
longitudinal studies. The first study was a 5 year prospective cohort study; “Gait Velocity 
as an Independent Predictor of Dementia in Older Persons with Mild Cognitive 
Impairment” which began recruitment of participants in May of 2007. The main objective 
of this cohort study was to assess whether quantitative gait variables could predict 
progression to dementia. The second study was a 3 year prospective cohort study; ‘Gait 
Variability as a Predictor of Cognitive Decline and Risk of Falls in MCI’, participant 
recruitment began in November 2010 and involved follow up assessment every 6 months. 
This cohort study was primarily designed to determine if gait variability was associated 
with impairment in executive function (EF), attention and memory as well as determining 
the anatomical neural substrate of gait variability.  Lastly, the study entitled ‘Can 
cognitive enhancers reduce the risk of falls in older people with mild cognitive 
impairment (MCI)?’ began data collection in December 2009. This study was a 
randomized control trial and the main objective was to determine the effect of a cognitive 
enhancer (donepezil) on gait and balance performance in people with MCI over a 6 
month time frame.  
 
All projects were approved by the University of Western Ontario Health Sciences 
Research Ethics Board (Appendix A).  
 
2.2 Study Population 
 
 The three studies aforementioned initially recruited their samples in London, 
Ontario from the ‘Aging Brain and Memory Clinic’ at Parkwood Hospital, retirement 
homes, family physicians and the community. MCI participants were eligible to 
participate if there was a recent clinical diagnosis of MCI, aged 65 and older and the 
ability to walk without a mobility aid. Participants were excluded in these studies based 
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on the inability to understand English, any neurological disorder with residual motor 
deficits (e.g., stroke, parkinsonism, epilepsy, AD), a neuromuscular disorders or a history 
of hip or knee replacement 6 months prior to study participation, the use psychotropic 
medication which can affect motor performance, or active major depression (measured by 
a score >8/15 on the Geriatric Depression Scale) (Yesavage et al., 1982; Yesavage, 
1988).  The exclusion criteria were determined to reduce statistical noise presented by 
diseases or disabilities known to have detrimental effects on gait. 
 
 To obtain the study sample of MCI patients used in the secondary analysis 
performed for this thesis, participants needed to meet the inclusion criteria of having 
scores on all cognitive testing outlined in section 2.3 and data for single and dual-task 
(DT) gait test conditions. Across the three studies there were a total of 130 unique 
individuals and 72 met the inclusion criteria for the present study.  
 
2.3 Medical and Cognitive Status Assessments 
 
Trained research assistants completed a comprehensive interview for 
sociodemographic characteristics, co-morbidities, medications, history of falls within 12 
months, self-reported levels of physical activity (Physical Activity Scale for the Elderly) 
and preserved functionality in activities of daily living (BADL) (Katz score for ADLs 
and Lawton-Brody score for Instrumental Activities of Daily living (IADLs) (Lawton & 
Brody, 1969). Patients were also administered the Geriatric Depression Scale (GDS) is a 
reliable and valid screening tool used for measuring depressive symptoms in the elderly. 
Scores range from 0-15, where higher scores reflect severity of depression. A cut off 
score of >6 was used to exclude participants (Sheikh et al., 1991).  
 
Objective global cognitive status was assessed using the MMSE (scored 0-30) 
(Folstein, Folstein & McHug, 1975) and the MoCA (scored 0-30) (Nasreddine et al., 
2005), with lower scores indicating poorer performance of each test. Cognitive 
impairment in the MCI population was operationalized by a combination of a low MoCA 
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score (< 26) and normal MMSE (>26) (Nasreddine et al., 2005). These scores were used 
for descriptive purposes only. 
 
The Trail Making Test (TMT) version A and B, a well-established psychomotor 
test, was used to determine deficits in executive cognitive functions (Coppin et al., 2006; 
Lezak, 1995; Strauss, Sherman & Spreen, 2006). Version A was used in this analysis to 
assess attention and required participants to draw lines connecting consecutively 
numbered circles (1-25) randomly ordered on a page. Version B added a measure of 
cognitive flexibility, mental shifting and planning (Corrigan & Hinkeldey, 1987; Kortte, 
Horner & Windham, 2002). Participants were asked to draw lines to connect circles in an 
alternating order of letters and numbers on a page. Both versions are timed and the time 
to completion is measured in seconds. The difference between version B and A (ΔTMT) 
was used in this study to model EF. Delta TMT is used to control for the effect of motor 
speed and is considered a more accurate measure of EF (Lezak, 1995).  
 
Digit Span Test (forwards and backwards) was used to measure attention. In Digit 
Span Test forward (DSTF), participants are asked to repeat a list of random numbers 
starting at two digits and increasing to eight in the same order (scored 0-16). In Digit 
Span Test backwards (DSTB), they are then asked to listen to a series of numbers and 
repeat them in the reverse order (scored 0-14) (Wechler, 1987). DSTF is more a measure 
of immediate attention and DSTB in this study was used as a measure of complex 
attentional tasks (Choi et al., 2014; Lezak, 1995; Yogev-Seligmann et al., 2008). The 
difference between the digit span forward and backward test (ΔDST) was used in this 
analysis as an index of the central executive component of working memory, where better 
scores indicated better memory (Liu-Ambrose, Nagamatsu, Graf, Beattie, Ashe & Handy, 
2010). 
 
The Letter Number Sequencing Test (LNS) was used to assess working memory. 
The test examined the ability to retain and process a sequence of letters and numbers and 
then were asked to recite numbers first in increasing order followed by letters in 
alphabetical order (scored 0-21) (Becker & Morris, 1999). 
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The Rey Auditory Verbal Learning Test (RAVLT) was used to assess episodic 
memory. The participant listens to list of 15 nouns (List A) repeated five times, after each 
trial they are asked to recall as many words as possible from the list. A second 
interference list (List B) is presented and the participant is asked to recall as many words 
as they can from List B. After the interference trial, the participant is immediately asked 
to recall the words from List A and the score is calculated based on the number nouns 
retained from List A (Lezak, 1995). 
 
The reduced 15-item version of the Boston Naming Test (BNT) was used to 
assess the language domain, requiring participants to clearly identify and verbalize the 
objects depicted in pictures. The score (0-15) was calculated from those items correctly 
named spontaneously and named correctly after semantic cues (Stern et al., 1992). 
 
2.4 Gait Assessment  
 
In a well-lit area, gait performance was assessed using 6m x 0.64m electronic 
walkway system (GAITRite®) with pressurized sensors activated with each footfall as a 
subject walks over the mat. A connected personal computer displayed electronic imprints 
and collected spatial and temporal gait parameters from each footfall. To measure steady 
state walking, 1 meter acceleration and deceleration regions were added to either end of 
the mat but were not included in gait parameter calculations. The GAITRite® system has 
shown excellent validity and reliability collecting spatial and temporal characteristics in 
various populations, including the elderly (Bilney et al., 2003; McDonough et al., 2001; 
Verghese et al., 2002). Gait velocity (cm/s), stride time (msec), stride length (cm), step 
width (cm) and double support time (msec) were the primary variables of interest and 
measured under single and cognitively challenging DT conditions. The variability in four 
gait parameters (stride time, stride length, double support time and step width) was 
quantified using the CoV (CoV= [(SD/Mean) x 100]). Because the SD is reported in the 
same unit as the mean, a measurement scale with larger units (e.g. 50 to 100) will not 
necessarily have a larger SD than a measurement scale with smaller units (e.g. 1 to 50) 
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even if the shapes of the two frequency distributions are different, and thus the degree of 
dispersion is identical.  This property invalidates the use of the SD to directly compare 
variability across different scales.  By dividing the SD by the mean, the CoV becomes a 
standardized estimate of dispersion, which can then be directly compared between scales 
based on different units. The variables were selected based on the interrelationship, 
between cognitive control of gait, stability, posture and fall risk in the elderly described 
in the literature (Brach et al., 2005; Hausdorff, 2001; Hausdorff, 2005; Montero-Odasso, 
2012). Other gait characteristics captured by the GAITRite® system were not included 
for this analysis because of the high correlation with the included variables.  
 
Participants were asked to walk at a self-selected usual comfortable pace while 
completing each walking trial. The single task condition consisted of simply walking the 
length of the mat. The DT conditions consisted of counting backwards from 100, serial 7 
subtractions from 100 and naming animals out loud. These conditions were selected 
based on previous research indicating arithmetic tasks relies on attention and working 
memory (Hittmair-Delazer, Semenza & Denes, 1994), where naming animals is related to 
verbal fluency (Weiss et al., 2003). Standardized verbal instructions were given before 
each walking condition and did not provide instruction on task prioritization during the 
DT conditions 
 
2.5 Statistical Analysis 
 
Baseline demographic and medical characteristics of the study sample were 
summarized using means, standard deviations (SD) or frequencies expressed as a 
percentage as appropriate. The CoV was calculated for the gait variability of four 
parameters (stride time, stride length, step width and double support time). Preliminary 
analysis of the raw data identified the presence of outliers, these cases were further 
investigated to ensure absence of measurement error. The normality of the gait 
characteristics were evaluated with skewness, kurtosis and normality tests. Log 
transformations were used to obtain normal distribution in highly skewed gait variability 
parameters (dependant variable) and can be seen in Appendix B.  
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Pearson correlation analysis between each of the gait parameters was completed 
to determine highly correlated variables. A correlation co-efficient greater than 0.6 were 
considered highly correlated and were excluded from the analysis. 
 
 One way analysis of variance (ANOVA) with repeated measures design was 
performed to determine mean difference between all four walking conditions (one 
independent variable with four levels) and gait characteristics (dependant variables). 
Statistically significant findings from the ANOVA were followed by post-hoc analysis of 
pairwise comparisons using the Bonferroni test for all possible comparisons to adjust for 
multiple comparisons and to reduce chance of type I errors. Analysis was completed for 
the mean, the CoV and log transformed gait variables.  
 
Multiple linear regression analysis was performed to further investigate cross- 
sectional associations between cognition (as measured by TMTA & B, DSTs, LNS, 
RAVLT & BNT) and gait (velocity, stride time, stride length, step length and double 
support time) with and without DTs. Gait variables were the dependant variables and 
exposure variables of interest were the neuropsychological test scores.  All assumptions 
for linear regression models were fulfilled by examination of scatter-plot and histogram 
graphs. The regression analysis was adjusted for age, body mass index (BMI), total 
number of medications and total number of co-morbidities to account for potential 
confounding effects. All data was analyzed using Statistic Package for the Social 
Sciences (SPSS) software version 20.0 (SPSS, Chicago, IL). Statistical significant was 
accepted at 0.05 for all analysis.   
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Chapter 3: RESULTS 
 
3.1 Study Population and Demographics  
 
For this study, data on 72 participants with mild cognitive impairment (MCI) 
were used for our initial sample. Four subjects were excluded from the study, due to an 
inability to speak or understand English (1) or measurement error (3). The final sample 
consisted of 68 participants. All demographic characteristics are summarized in Table 
3.1. The average age of the participants was [Mean (SD)] 74.1 (10.1) years, of whom 
54% were male with an average Body Mass Index (BMI) of 26.8 (4.5). Depression scores 
were low and all subjects were able to perform instrumental activities of daily living.   
 
Table 3.1: Demographic characteristics of study participants in total sample  
 
Variable Mean ± Standard Deviation 
n=68 
Age (years) 
Level of Education (years) 
Gender (%) 
      Male 
      Female 
Body Mass Index (height/meters²) 
Total Number of Medications  
Total Number of Co-Morbidities 
General Depression Scale (Total Score) 
Lawton Brody ADL  Scale (Total Score) 
Lawton Brody IADL Scale (Total Score) 
75.9 ± 6.9 
12.9 ± 3.1 
 
54% 
46% 
26.8 ± 4.5 
7.2 ± 4.2 
6.6 ± 2.7 
2.0 ± 1.9 
5.91 ± 7.3 
7.69 ± 1.2 
 
Notes: ADL =Activities of Daily Living, IADL= Instrumental activities of daily living, n 
= sample size 
 
Participants neuropsychological test scores are summarized in Table 3.2. 
Participants mean scores on global cognitive tests were consistent with a diagnosis for 
MCI since a pattern of normal MMSE scores (>26) of 28.2 (1.8) and low MoCA scores 
of 24.0 (3.1) was found among participants. Performance on Trial Making Test A 
(TMTA) and B (TMT B) and Rey Auditory Verbal Learning Test (RAVLT) were below 
normal ranges, while the mean performance in Digit Span Tests (DST), Letter Number 
Sequencing (LNS) and Boston Naming Test were within normative data for older adults 
44 
   
 
 
over 65 (Choi et al., 2014; Montero-Odasso et al., 2009 Strauss, Sherman & Spreen, 
2006; Tombaugh, 2004). 
 
Table 3.2: Descriptive statistics of neuropsychological tests (raw scores) in 68 
participants with mild cognitive impairment  
Variable  Mean ± Standard Deviation 
MMSE  28.2 ± 1.8 
MoCA 24.0 ± 3.1  
TMT A 48.1 ± 16.1  
TMT B 131.7 ± 77.7 
∆TMT 83.6 ± 68.5 
DST-F 11.03 ± 1.9 
DST-B 7.03 ± 2.3 
∆DST 4.0 ± 2.2  
LNS 7.6 ± 2.5  
RAVLT  4.75 ± 2.8  
BNT  13.5 ± 1.3 
 
Notes: MMSE= Mini Mental State Examination, MoCA= Montreal Cognitive 
Assessment, TMT=Trail Making Test, DST-F= Digit Span Test Forward, DST-B=Digit 
Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory Verbal 
Learning Test, BNT= Boston Naming Test, ∆=delta  
  
3.2 Gait Performance  
 
3.2.1 Exclusion of Gait Variables  
 
Pearson correlation analysis identified significant correlations between gait 
variables and the following variables were excluded due to their high correlation with the 
included measures. The excluded variables were step length, swing time and step time 
(Table 3.3). 
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Table 3.3: Pearson Correlation Matrix between all gait variables captured by the GAITRite® system. 
 
 
Note: bold values indicate statistical significance at p<0.05 
Pearson Correlation Co-Efficient (p-values)   
 Velocity Stride 
Time 
Step 
Time 
Stride 
Length 
Step 
Length 
Double 
Support 
Time 
Swing 
Time 
Stride 
Width 
Step Width 
Velocity 1 -0.643 
(<0.001) 
-0.508 
(<0.001) 
0.913 
(<0.001) 
0.912 
(<0.001) 
-0.685 
(<0.001) 
-0.155 
(0.206) 
-0.189 
(0.122) 
0.794 
(<0.001) 
Stride Time -0.643 
(<0.001) 
1 0.821 
(<0.001) 
-0.293 
(0.015) 
-0.293 
(<0.001) 
0.598 
(<0.001) 
0.704 
(<0.001) 
0.052 
(0.674) 
-0.275 
(0.028) 
Step time -0.508 
(<0.001) 
0.821 
(<0.001) 
1 -0.222 
(0.68) 
-0.223 
(0.068) 
0.449 
(<0.001) 
0.650  
(<0.001) 
-0.079 
(0.522) 
-0.201 
(0.111) 
Stride 
Length 
0.913 
(<0.001) 
-0.293 
(<0.001) 
-0.222 
(0.068) 
1 0.999 
(<0.001) 
-0.559 
(<0.001) 
0.171 
(0.163) 
-0.206 
(0.091) 
0.862 
(<0.001) 
Step Length 0.912 
(<0.001) 
-0.293 
(<0.001) 
-0.223 
(0.068) 
0.999 
(<0.001) 
1 -0.560 
(<0.001) 
0.174 
(0.156) 
-0.211 
(0.084) 
0.0864 
(<0.001) 
Double 
Support 
Time 
-0.685 
(<0.001) 
0.598 
(<0.001) 
0.449 
(<0.001) 
-0.559 
(<0.001) 
-0.560 
(<0.001) 
1 -0.023 
(0.853) 
0.234 
(0.055) 
-0.531 
(<0.001) 
Swing Time -0.155 
(<0.001) 
0.704 
(<0.001) 
0.650 
(<0.001) 
0.171 
(0.163) 
0.174 
(0.156) 
-0.023 
(0853) 
1 -0.200 
(0.102) 
0.183 
(0.148) 
Stride Width -0.189 
(0.122) 
0.052 
(0.674) 
-0.079 
(0.522) 
-0.206 
(0.91) 
-0.211 
(0.084) 
0.236 
(0.055) 
-0.200 
(0.102) 
1 -0.086  
(0.498) 
Step Width 0.794 
(<0.001) 
-0.275 
(0.028) 
-0.201 
(0.111) 
 
0.862 
(<0.001) 
0.864 
(<0.001) 
-0.531 
(<0.001) 
0.183 
(0.148) 
-0.086 
(0.498) 
1 
4
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3.2.2 Effects of Dual-Task Testing 
 
All participants were able to perform the walking tasks. The mean number of 
responses and errors during the dual task conditions are presented in Table 3.4. Mean and 
gait data during single and DT conditions (counting backwards by 1’s, serial 7 
subtractions and naming animals), as well as significant differences between each dual 
task condition are summarized in Table 3.5. There was a significant reduction in mean 
gait speed across all walking conditions (p> 0.001). The CoV and log transformed 
variables showed similar results. Mean CoV parameters, except for the CoV of double 
support time, were significantly increased across the four walking conditions (p> 0.001). 
Bonferroni correction analysis showed no significant difference between walking 
conditions and double support time variability.  
 
Table 3.4: Response totals and errors for each dual task walking condition. 
 
 Counting by 
1’s Gait 
Serial 7 
Subtractions 
Gait 
Naming 
Animals Gait 
Total Number of Responses 
Mean ± SD 
 
11.0 ± 2.01 
 
4.2 ± 1.80  
 
6.8 ± 1.81 
Total Number of Errors 
Mean ± SD 
 
.03 ± .17 
 
.51 ± .89 
 
---- 
 
Notes: SD= standard deviation  
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Table 3.5: One-way ANOVA with repeated measures for baseline gait characteristics for all walking conditions.  
 
Usual Gait  Counting by 
1’s Gait 
Naming 
Animals Gait 
Serial Seven’s 
Gait 
p-value 
Velocity  
109.0 ± 21.3 
    
Mean (cm/s): 103.5 ± 25.4 93.6 ± 26.6 88.2 ± 28.5 <.001 
Stride Time        
Mean±SD(msec): 1146.2 ± 96.7 1212.6 ± 150.0 1307.2 ± 210.6
a
 1402.0 ± 377.1
a
 <.001 
CoV(%)±SD: 2.6 ± 1.3 2.7 ± 2.0
 a
 4.4 ± 2.9
 a,b
 5.8 ± 5.6
b
 <.001 
CoV (log) ±SD: 0.41 ± 0.11 0.43 ± 0.30
a
 0.64 ± 0.46
a,b
 .076 ± 0.75
b
 <.001 
Stride Length  
Mean±SD (cm): 
 
124.1 ± 19.3
a
 
 
123.5 ± 21.9
a
 
 
118.8 ± 24.4
b
 
 
117.2 ± 23.6
b
 
 
<.001 
CoV(%)±SD: 3.4 ± 2.2
a 
4.0 ± 2.3
a,b 
4.6 ± 3.3
a,b 
5.3 ± 4.5
b 
<.001 
CoV (log) ±SD: 0.53 ± 0.34
 a
 0.60 ± 0.36
a,b
 0.66 ± 0.52
a,b
 0.72 ± 0.65
b
 <.001 
Double Support Time       
Mean±SD (sec):  .37 ± .07 .39 ± .08 .44 ± .13 .47 ± .13 <.001 
CoV(%)±SD:  7.5 ± 6.0
a
 8.0 ± 4.2
a
 8.3 ± 4.8
a
 9.1 ± 5.2
a
 .270 
CoV (log) ±SD: 0.88 ± 0.78
a
 0.90 ± 0.62
a
 0.92 ± 0.68
a
 0.96 ± 0.71
a
 .091 
Step Width:      
Mean±SD (cm) 63.9 ± 9.5
 a
 62.6 ± 10.0
a
 60.4 ± 11.0
b
 60.5 ± 11.1
b
 <.001 
CoV(%)±SD: 4.8 ±. 2.5
a
 5.7 ± 2.5
a,b
 6.4 ± 3.5
 b
 7.1 ± 4.8
b
 <.001 
CoV (log) ±SD: 0.68 ± 0.40
 a
 0.75 ± 0.39
a,b
 0.80 ± 0.54
b
 0.85 ± 0.68
 b
 <.001 
 
Notes:  ± SD= standard deviation, one-way ANOVA (analysis of variance) with repeated measures CoV= coefficient of 
variation, statistical significance set at p<0.05, a,b denote statistically significant between group differences determined by the 
Bonferroni test, values with the same letter are not significantly different from one another, different letters or no letters 
indicate statistical differences. 
4
7
 
 
48 
   
 
 
3.2.3 Associations between Specific Cognitive Domains and Quantitative Gait 
Variables  
 
 Results from the unadjusted linear regression analysis comparing individual 
cognitive test scores on gait variables during single task and dual-task (DT) gait are 
presented in Appendix C. In brief, during the single task usual gait speed condition poor 
scores on measures of executive function (EF) and attention were significantly associated 
with increased (worse) double support time. Poorer scores on measures of working 
memory were significantly associated with increased (worse) stride time and poorer 
performance on language tests were associated with decreased (worse) stride length. 
During DT conditions, poorer performance on measures of attention, working memory, 
episodic memory and language were significantly associated with poorer gait 
performance. 
 
 In the adjusted linear regression analysis, during the single task usual walking 
speed condition increased double support time remained significantly associated with 
poorer scores on cognitive measures of attention and executive function (EF) (Table 3.6). 
During the dual-task (DT) conditions of counting backwards by 1’s gait, poor 
performance on cognitive tests measuring attention remained significantly associated 
with decreased gait velocity and increased stride time. Poor performance on working 
memory tests remained significantly associated with decreased velocity and increases in 
stride time and double support time. Better scores on tests of episodic memory were 
significantly associated with decreases in double support time and better scores on tests 
assessing language were significantly associated with increased stride length (Table 3.7). 
During the DT condition of naming animals, decreased velocity and step width were 
associated with poor working memory scores (Table 3.8). During serial seven subtraction 
gait, no significant associations were found (Table 3.9).   
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Table 3.6: Adjusted linear regression analysis comparing the associations of cognitive test score on the outcome of gait 
variables during single task usual gait speed. 
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during single task gait:  
Velocity (cm/s) Stride Time (msec) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.22 (-0.47, 0.03) 
p= .104 
0.55 (-0.70, 1.8) 
p= .381 
-0.181 (-0.44, 0.074) 
p= .161 
1.18 (0.27 – 2.10) 
p= .012 
-0.080 (-0.215 - 0.055) 
p=.240 
∆TMT  -0.024 (-0.082, 0.033) 
p= .399 
0.100 (-0.186, 0.39) 
p= .486  
-0.014 (-0.074, 0.045) 
p=.627  
0.223 (0.016 - 0.44) 
p= .016  
-0.015 (-0.046 - 0.016) 
p= .326  
DST-B 0.72 (1.02, 2.46) 
p= .411 
-4.06 (-12.68, 4.55) 
p= .349 
0.41 (-1.38, 2.20) 
p= .649 
-3.66 (-10.27 – 2.95) 
p=.273 
0.21 (-0.754 – 1.18) 
p= .663 
∆DST  -1.02 (-2.88, 0.84) 
p= .278 
5.20 (-4.02, 14.43) 
p= .264 
-0.54 (-2.46, 1.39) 
p= .579 
2.87 (-4.27 – 10.01) 
p= .425  
-0.65 (-1.67 - 0.375) 
p= .210 
LNS 1.89 (-0.38, 2.75) 
p= .134 
0.39 (-7.52, 8.30) 
p= .921  
1.50 (-0.142, 3.04) 
p= .074 
-4.74 (-10.71 – 1.23) 
p= .117  
0.55 (-0.313 – 1.42) 
p= .206 
RAVLT  -0.15 (-1.61, 1.30) 
p= .833 
-3.52 (-10.67,  3.63)  
p= .329  
-0.54 (-2.02, 0.94) 
p= .470 
-3.14 (-8.63 – 2.35)  
p= .257 
-0.056 (-0.84 - 0.73) 
p= .887 
BNT  1.67 (-1.40, 4.74) 
p= .280 
6.53 (-8.74, 21.81) 
p= .396  
2.91 (-0.182, 5.99) 
p= .065 
-7.77 (-19.44 – 3.90) 
p= .188 
1.48 (-0.179 – 3.13) 
p= .080  
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table 3.7: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait  
 
variables during dual task testing using a secondary task of counting backwards by 1’s.  
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during counting by 1’s gait:  
Velocity (cm/s) Stride Time (msec) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.40 (-0.728, -0.064) 
p= .020 
2.17 (-0.002, 4.34) 
p= .050 
-0.22 (-0.510, 0.073) 
p= .137  
0.59 (-0.57, 1.76) 
p= .312 
-0.11 (-.247, .031) 
p=.124 
∆TMT  -0.058 (-0.136, 0.020) 
p= .140 
.41 (-0.096, 0.908) 
p=.111 
-0.024 (-0.092, 0.045) 
p= .496  
0.26 (0.001,  0.522) 
p= .001 
-0.013 (-0.045, 0.020) 
p= .440 
DST-B 2.26 (-0.073, 4.59) 
p= .057 
-16.42 (-31.33,  -1.50) 
p= .032 
0.880 (-1.19, 2.96) 
p= .399 
-5.35 (-13.37,  2.65) 
p=.186 
0.076 (-0.927, 1.08) 
p= .880 
∆DST  -3.0 (-5.45, -0.512) 
p= .019 
22.18 (6.51, 37.85) 
p= .006 
-1.15 (-3.37, 1.07) 
p= .304  
10.23 (1.88, 18.56) 
p= .017 
0.75 (-1.80,  0.309) 
p= .162 
LNS 1.80 (-0.35, 3.94) 
p= .099 
-4.48 (-18.58, 9.62) 
p= .528 
1.70 (-0.156, 3.55) 
p= .072 
-4.04 (-11.39. 3.31) 
p= .276 
0.47 (-0.49, 1.37) 
p= 298 
RAVLT  0.12 (-1.88,  2.12) 
p= .906 
-7.90 (-20.63, 4.83) 
p= .220 
-0.47 (-2.20, 1.26) 
p= .593 
-6.75 (-13.29,  -0.22) 
p=.043 
-0.24 (-1.05, 0.57) 
p= .557 
BNT  3.08 (-1.11, 7.26) 
p=.147 
-3.85 (-31.30, 23.61) 
p=.780 
3.79 (.22, 7.35) 
p= .038 
-10.57 (-24.72, 3.58) 
.140 
1.21 (-.527, 2.94) 
p=.169 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
 
 
 
 
 
 
5
0
 
 
51 
   
 
 
Table 3.8: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait  
 
variables during dual task testing using a secondary task of naming animal’s.  
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during naming animal’s gait:  
Velocity (cm/s) Stride Time (msec) Stride Length (cm) Double Support Time 
(sec) 
Step Width (cm) 
TMT A  -0.27 (-0.64, 0.11) 
p= .159 
2.64 (-0.58, 5.87) 
p= .106 
-0.120 (-0.45, 0.22) 
p= .477 
0.93 (-1.04, 2.90) 
p=.351  
-.096 (-0.250, 0.058) 
p= .219 
∆TMT  -0.043 (-.13, 0.041) 
p= .310 
0.46 (-0.28, 1.20)  
p= .223  
-0.007 (-0.083, 0.070) 
p=.864 
0.300 (-0.14, 0.74) 
p= .181 
-0.011 (-0.047,  0.025) 
p= .543 
DST-B 1.80 ( -0.76, 4.36) 
p= .164 
-8.15 (-30.75, 14.46)  
p= .474 
1.14 (-1.15, 3.44) 
p= .324 
-2.73 (-16.34, 10.90) 
p= .690 
0.45 (-0.65, 1.5) 
p= .414 
∆DST  -3.36 (-6.02, -0.681) 
p= .015 
20.08 (-3.90, 44.06) 
p= .099 
-2.01 (-4.46, 0.45) 
p= .107  
11.16 (-3.30, 24.63) 
p= .128 
-1.20 (-2.35, -0.060) 
p= .039 
LNS 1.06 (-1.33, 3.46) 
p= .378 
-3.05 (-24.11, 18.01) 
p= .773 
1.34 (-0.788, 3.46) 
p= .213 
-4.49 (-17.01, 8.23) 
p= .489 
0.48 (-0.512, 1.48) 
p=.335 
RAVLT  0.008 (-2.14, 2.16) 
p= .994 
-11.23 (-28.6, 7.30) 
p= .230 
-0.76 (-0.267, 1.14) 
p=.427  
-.8.42 (-19.48, 2.65) 
p= .133 
-0.23 (-1.13, 0.660) 
p= .602 
BNT  1.77 (-2.78,  6.33) 
p= .440  
-9.40 (-49.34, 30.56) 
p= .640 
20.74 (-1.29, 6.77) 
p= .178 
-20.75 (-44.20,  2.71) 
p= .082 
0.99 (-0.938,  2.91) 
p= .309 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table 3.9: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait  
 
variables during dual task testing using a secondary task of serial seven subtractions.  
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during serial seven subtraction gait:  
Velocity (cm/s) Stride Time (msec) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.38 (-0.800, 0.047) 
p= .081 
3.12 (-2.82, 9.22) 
p= .293 
-0.18 (-0.51, 0.151) 
p= .280 
0.69 (-1.32, 2.69) 
p= .497 
-0.12 (-0.28, 0.042) 
p= .146 
∆TMT  -0.064 (-0.62, 0.034) 
p=.197 
0.52 (-.86, 1.91) 
p= .452 
-0.021 (-0.097, 0.055) 
p= .584 
0.33 (-0.12, 0.78) 
p= .149 
-0.019 (0-.056, 0.018) 
p= .305 
DST-B 1.93 (-1.03, 5.0) 
p= .197  
-16.34 (-58.2, 25.52) 
p= .438 
1.10 (-1.12, 3.40) 
p= .342 
-2.79 (-16.67, 11.11) 
p= .690 
0.45 (-0.70, 1.59) 
p= .437 
∆DST  -0.85 (-7.03, 5.33) 
p= .785 
-5.01 (-91.61, 81.43) 
p= .907 
-0.076 (-4.83, 4.69) 
p= .975 
12.21 (-16.22, 40.63) 
p= .394 
-.302 (-2.61, 2.0) 
p= .794 
LNS 1.01 (-1.73, 3.74) 
p= .465  
-5.37  (-43.74, 33.0) 
p= .781  
1.36 (-0.73, 3.44) 
p= .199 
-2.46 (-15.13, 10.22) 
p= .700 
0.65 (-0.38, 1.67) 
p=.213 
RAVLT  -0.52 (-3.02, 1.98) 
p= .678  
11.10 (-23.77, 45.98) 
p= .527 
-0.83 (-2.74, 1.09) 
p= .392  
-1.66 (-13.22, 9.90) 
p= .775 
-0.15 (-1.06, 0.78) 
p= .752 
BNT  1.23 (-4.1, 6.55) 
p= .646  
11.63 (-62.89, 86.15) 
p= .756 
2.12 (-2.0, 6.19) 
p= .302 
-4.12 (-28.79, 20.46) 
p= .737 
1.08 (-0.91, 3.07) 
p= .282 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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3.2.4 Associations between Specific Cognitive Domains and Gait Variability 
Parameters  
 
 Overall, a greater number of associations were found between deficits in 
cognitive performance and increases in gait variability parameters across all walking 
conditions with the exception of serial subtractions gait. Stride time variability (STV) 
was found to be the most consistent gait variability parameter, associated with the most 
cognitive domains across single and the three DT conditions. Results from the unadjusted 
linear regression analysis comparing the associations of individual cognitive domains on 
an outcome of gait variability are presented in Appendix D. In brief, during single task 
usual gait poor performance in measures of EF and working memory were significantly 
associated with worse gait performance in STV and stride length variability. During DT 
conditions, deficits in EF, attention, working memory, episodic memory and language 
were all significantly associated with increases in gait variability parameters.  
 
 In the adjusted linear regression analysis, during single task usual gait speed 
deficits in EF and working memory were significantly associated with increases in the 
variability of stride time and stride length. Double support time showed statistically 
significant associations with deficits in working memory and episodic memory (Table 
3.10). During the DT walking condition of counting backwards by 1’s deficits in EF were 
significantly associated with increases in STV. Deficits in attentional cognitive domains 
were significantly associated with increases in STV and stride length variability. Poorer 
scores on measures of working memory were associated with increases in STV, stride 
length variability and double support time variability. Better performance on tests of 
episodic memory was associated with decreases in STV and double support time 
variability (Table 3.11). During the DT walking condition of naming animals, deficits in 
attentional domains were significantly associated with increased STV and stride length 
variability. Poorer performance on tests of working memory was associated with 
increased STV, stride length variability and step width variability. Better scores on tests 
of the language domain were significantly associated with decreased STV (Table 3.12). 
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There remained no significant associations found during serial seven subtraction gait 
between cognitive test scores and gait variability measures (Table 3.13).  
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Table 3.10: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait 
variability during single task usual gait speed. 
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during single task gait (log):  
Stride Time (msec) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.0024 (-0.003, 0.003) 
p= .987 
0.001 (-0.004, 0.006) 
p= .729 
0.000 (-0.004, 0.004) 
p= .927 
-0.001 (-0.004, 0.002) 
p= 0.550 
∆TMT   0.001 (0.00, 0.001) 
p= .045 
0.001 (0.00, 0.002) 
p= .023 
0.001 (0.00, 0.002) 
p= .059 
0.00 (0.00, 0.001) 
p= .234 
DST-B -0.014 (-0.034, 0.007) 
p= .185 
-0.020 (-0.054, 0.014) 
p= .234 
0.001 (-0.026, 0.028) 
p= .945 
-0.004 (-0.027, 0.020) 
p= .763 
∆DST  0.049 (0.008, 0.089) 
p= .020 
0.080 (0.012, 0.148) 
p= .022 
0.054 (0.001, 0.108) 
p= .046 
0.039 (-0.007, 0.085) 
p= .097 
LNS -0.031 (-0.048, -0.014) 
p= .001 
-0.047 (-0.076, -0.018) 
p= .002 
-0.022 (-0.046, 0.002) 
p= .075 
-0.019 (-0.040, 0.002) 
p= .071 
RAVLT  -0.014 (-0.031, 0.003)  
p= .094 
-0.023 (-0.051, 0.005) 
p= .106 
0.013 (-0.010, 0.035) 
p= .026 
-0.017 (-0.036, 0.001)  
p= .069 
BNT  -0.002 (-0.039, 0.034) 
p= .903 
-0.005 (-0.066, 0.056) 
p= .866 
-0.039 (-0.086, 0.008)  
p= .099 
0.006 (-0.035, 0.047) 
p= .777 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table 3.11: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait 
variability during dual task testing using a secondary task of counting backwards by 1’s. 
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during counting by 1’s gait (log):  
Stride Time (msec) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.004 (0.00, 0.007) 
p= .026 
0.006 (0.002, 0.010) 
p= .002 
0.002 (-0.002, 0.005)  
p= .349 
0.002 (0.00, 0.005) 
p= .071 
∆TMT 0.001 (0.00, 0.002)  
p= .006 
0.001 (0.00, 0.002) 
p= .081 
0.001 (0.00, 0.001)  
p= .168 
0.00 (0.00, 0.001) 
p= .259 
DST-B -0.023 (-0.046, -0.001) 
p= .043 
-0.030 (-0.057, -0.003)  
p= .030 
-0.015 (-0.037, 0.008) 
p= .192 
-0.010 (-0.029, 0.010) 
p= .322 
∆DST  0.025 (0.001, 0.049) 
p= .041 
0.015 (-0.016, 0.045) 
p= .338 
0.006 (-0.018, 0.030) 
p= .599 
0.005 (-0.016, 0.026) 
p= .647 
LNS -0.017 (-0.038, 0.003) 
p= .101 
-0.037 (-0.061, -0.013) 
p= .003 
-0.024 (-0.044, -0.005) 
p= .016 
-0.014 (-0.031, 0.003)  
p= .106 
RAVLT  -0.023 (-0.042, -0.005) 
p= .013 
-0.012 (-0.035, 0.012)  
p= .318 
-0.023 (-0.041, 0.005) 
p= .012 
-0.011 (-0.023, 0.005) 
p=.115 
BNT  -0.031 (-0.071, 0.101) 
p= .134 
-0.030 (-0.079, 0.019) 
p= .231 
-0.025 (-0.064, 0.014)  
p= .209 
0.009 (-0.034, 0.34) 
p=.996 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table 3.12: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait 
variability during dual task testing using a secondary task of naming animal’s.  
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during naming animal’s gait (log):  
Stride Time (msec) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.006 (0.001, 0.010) 
p= .011 
0.003 (-0.001, 0.007) 
p= .181 
0.00 (-0.003, 0.004) 
p= .949 
0.002 (-0.002, 0.005)  
p=.282 
∆TMT  -0.004 (-0.010, 0.001) 
p= .122 
-0.003 (-0.009, 0.002) 
p= .218 
-0.001 (-0.006, 0.003)  
p= .565 
-0.001 (-0.006, 0.004) 
p= .636 
DST-B -0.018 (-0.048, 0.012) 
p= .236 
-0.029 (-0.056, -0.002) 
p= .037 
-0.003 (-0.028, 0.021) 
p= .777 
-0.022 (-0.046, 0.003) 
p= .081 
∆DST  0.025 (-0.008, 0.057) 
p= .131 
0.042 (0.014, 0.071) 
p= .004 
0.009 (-0.017, 0.036) 
p= .492 
0.044 (0.020, 0.068) 
p= .001 
LNS -0.029 (-0.057, -0.002) 
p= .038 
-0.021 (-0.047, 0.004) 
p=.101 
-0.004 (-0.026, 0.019) 
p= .745 
-0.011 (-0.033, 0.012) 
p= .348 
RAVLT  -0.004 (-0.029, 0.022) 
p= .767 
-0.009 (-0.032, 0.015) 
p= .464 
0.002 (-0.018, 0.023) 
p= .817 
-0.101 (-0.030, 0.010) 
p= .331 
BNT  -0.067 (-0.118, -0.015) 
p= .012 
-0.026 (-0.076, 0.023) 
p= .293 
-0.018 (-0.061, 0.025)  
p= .410  
-0.018 (-0.062, 0.025) 
p= .404 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table 3.13: Adjusted linear regression analysis comparing the association of cognitive test scores on the outcome of gait 
variability during dual task testing using a secondary task of serial seven subtractions  
 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during serial seven subtraction gait (log):  
Stride Time (msec) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.003 (-0.002, 0.007) 
p= .237 
0.00 (-0.004, 0.005)  
p= .832 
-0.002 (-0.006, 0.002)  
p= .382 
0.001 (-0.003, 0.005) 
p= .620 
∆TMT   0.001 (-0.001, 0.002) 
p= .326 
0.00 (-0.001, 0.001) 
p= .724 
0.00 (-0.001, 0.001) 
p= .561 
0.00 (-0.001, 0.001)  
p= .491 
DST-B -0.005 (-0.037- 0.028) 
p= .769 
-0.025 (-0.056, 0.006) 
p= .110 
0.010 (-0.017, 0.037) 
p= .472 
-0.010 (-0.039, 0.018) 
p= .467 
∆DST  0.029 (-0.005, 0.064) 
p= .091 
0.029 (-0.004, 0.062) 
p= .085 
0.007 (-0.022, .036) 
p= .635 
0.022 (-0.008, 0.057) 
p= .152 
LNS -0.008 (-0.037, 0.022)  
p= .613 
-0.016 (-0.045, 0.012) 
p= .252 
0.011 (-0.013, 0.036) 
p= .356 
-0.007 (-0.033, 0.018) 
p=.568 
RAVLT  0.016 (-0.011, -0.043) 
p= .245 
-0.001 (-0.028, 0.025) 
p= .916 
0.011 (-0.012, 0.033) 
p= .338 
-0.002 (-0.025, 0.021) 
p= .859 
BNT  -0.023 (-0.080, 0.035) 
p=.435 
0.042 (-0.013, 0.097) 
p= .128 
0.033 (-0.015, 0.080) 
p= .174 
0.036 (-0.013, 0.085) 
p= .149 
 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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3.2.5 Interpretations of Log Transformations   
 
 The log transformed variables do not make intuitive sense for clinical 
applications; therefore, examples of patients with good and poor cognitive test scores 
were selected to assist with the interpretation of the results for the gait variability 
regression analysis. STV and stride length variability were selected because they were 
found to be the most consistent of all variables in terms of associations with cognitive test 
scores. Since the dependant variable is log transformed and the independent variable is 
not, the beta co-efficient can be interpreted as: every 1 unit change in the independent 
variable is expected to multiply the original dependent variable by 10
b
, where
  b 
is the beta 
co-efficient.  
 
Figure 3.1: Linear regression analysis for the association of raw Trail Making Test 
A scores on the outcome of stride time variability (log) during counting backwards 
by 1’s gait.  
  
Notes: Cases numbered are ones used in example calculations, 1= good cognitive test 
score; 2= poor cognitive test score, y’= predicted dependant variable score 
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Trail Making Test A (attention):  
An individual with a good cognitive score on a measure of attention (23.16 seconds) 
would be predicted to have a STV value of 2.88:  
Log y’= B1X1 + a 
Log y’= 0.004x + 0.36 
Log y’= 0.004(23.16) + 0.36 
Log y’= 0.457 
Transformation back to original CoV %:  
y’= 100.457 
y’= 2.88 
An individual with a poor cognitive score on a measure of attention (103 seconds) would 
be predicted to have a STV value of 5.86:  
Log y’= B1X1 + a 
Log y’= 0.004x + 0.36 
Log y’= 0.004(103) + 0.36 
Log y’= 0.786  
Transformation back to original CoV%:  
y’= 100.786 
y’= 5.86 
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Figure 3.2: Linear regression analysis for the association of raw Δ Trail Making 
Test scores on the outcome of stride time variability (log) during counting 
backwards by 1’s gait.   
 
  
Notes: Cases numbered are ones used in example calculations, 1= good cognitive test 
score, 2= poor cognitive test score, y= predicted dependent variable 
 
Δ Trail Making Test (EF):  
An individual with a good cognitive score on a measure of EF (9 seconds) would be 
predicted to have a STV value of 2.75:  
Log y’= B1X1 + a 
Log y’= 0.001x + 0.43 
Log y’= 0.001(9) + 0.43 
Log y’= 0.439 
Transformation back to original CoV %:  
y’= 100.457 
y’= 2.75 
An individual with a poor cognitive score on a measure of EF (385 seconds) would be 
predicted to have a STV value of 6.53:  
log y' = 0.001x + 0.43
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Log y’= B1X1 + a 
Log y’= 0.001x + 0.43 
Log y’= 0.001(385) + 0.43 
Log y’= 0.815  
Transformation back to original CoV%:  
Y’= 1000.815 
Y’= 6.53 
 
Figure 3.3: Linear regression analysis for the association of raw Digit Span Test 
backwards scores on the outcome of stride length variability (log) during naming 
animal’s gait.  
  
Notes: Cases numbered are ones used in example calculations, 1= good cognitive test 
score, 2= poor cognitive test score, y’= predicted dependent variable score 
 
 
Digit Span Test Backwards (attention):   
 
An individual with a good cognitive score on another measure of attention (13) would be 
predicted to have a stride length variability value of 2.49  
Log y’= B1X1 + a 
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Log y’= -0.031x + 0.80 
Log y’= -0.031(13) + 0.80 
Log y’= 0.397 
Transformation back to original CoV %:  
y’= 100.397 
y’= 2.49 
An individual with a poor cognitive score on a measure of attention (3) would be 
predicted to have a stride length variability value of 5.09:  
Log y’= B1X1 + a 
Log y’= -0.031x + 0.80 
Log y’= -0.031(3) + 0.80 
Log y’= 0.707  
Transformation back to original CoV%:  
y’= 100.707 
y’= 5.09 
 
Figure 3.4: Linear regression analysis for the association of raw Δ Digit Span test 
scores on the outcome of stride time variability (log) during naming animal’s gait.  
 
Notes: Cases numbered are ones used in example calculations, 1= good cognitive test 
score, 2= poor cognitive test score, y`= predicted dependent variable score  
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Δ Digit Span Test (working memory): 
 
An individual with a good cognitive score on a measure of working memory (0) would be 
predicted to have a STV value of 1.11:  
Log y’= B1X1 + a 
Log y’= 0.030x + 0.045 
Log y’= 0.030(0) + 0.045 
Log y’= 0.045 
Transformation back to original CoV %:  
y’= 100.045 
y’= 1.11 
An individual with a poor cognitive score on a measure of working memory (10) would 
be predicted to have a STV value of 2.21:  
Log y’= B1X1 + a 
Log y’= 0.030x + 0.045 
Log y’= 0.030(10) + 0.045 
Log y’= 0.345 
Transformation back to original CoV%:  
y’= 100.345 
y’= 2.21 
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Figure 3.5: Linear regression analysis for the association of raw Letter Number 
Sequencing Test scores on the outcome of stride time variability (log) during naming 
animal’s gait.  
 
Notes: Cases numbered are ones used in example calculations; 1= good cognitive test 
score; 2= poor cognitive test score, y`= predicted dependent variable  
 
Letter Number Sequencing Test (working memory): 
An individual with a good cognitive score on a measure of working (14) would be 
predicted to have a STV value of 2.47  
Log y’= B1X1 + a 
Log y’= -0.027x + 0.77 
Log y’= -0.027(14) + 0.77 
Log y’= 0.392 
Transformation back to original CoV %:  
y’= 100.392 
y’= 2.47 
An individual with a poor cognitive score on a measure of working memory (2) would be 
predicted to have a STV value of 5.20:  
Log y’= B1X1 + a 
Log y’= -0.027x + 0.77 
y = -0.027x + 0.77
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Log y’= -0.027(2) + 0.77 
Log y’= 0.716 
Transformation back to original CoV%:  
y’= 100.716 
y’= 5.20 
 
Figure 3.6: Linear regression analysis for the association of raw Rey Auditory 
Verbal Learning Test Scores on the outcome of stride time variability (log) during 
counting backwards by 1’s gait.  
 
 
Notes: Cases numbered are ones used in example calculations, 1= good cognitive test 
score, 2= poor cognitive test score, y`= predicted dependent variable score  
 
Rey Auditory Verbal Learning Test (episodic memory): 
An individual with a good cognitive score on a measure of episodic memory (11) would 
be predicted to have a STV value of 2.45:  
Log y’= B1X1 + a 
Log y’= -0.02x + 0.61 
Log y’= -0.02(11) + 0.61 
Log y’= 0.457 
log y' = -0.02x + 0.61
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Transformation back to original CoV %:  
y’= 100.457 
y’= 2.45 
An individual with a poor cognitive score on a measure of episodic memory (0) would be 
predicted to have a STV value of 4.07:  
Log y’= B1X1 + a 
Log y’= -0.02x + 0.61 
Log y’= -0.02(0) + 0.61 
Log y’= 0.39  
Transformation back to original CoV%:  
y’= 100.39 
y’= 4.07 
 
Figure 3.7: Linear regression analysis for the association of raw Boston Naming 
Test scores on the outcome of stride time variability (log) during counting 
backwards by 1’s gait.  
 
Notes: Cases numbered are ones used in example calculations; 1= good cognitive test 
score; 2= poor cognitive test score  
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Boston Naming Test (language): 
An individual with a good cognitive score on a measure of language (15) would be 
predicted to have a STV value of 2.92:  
Log y’= B1X1 + a 
Log y’= -0.069x + 1.5 
Log y’= -0.069(15) + 1.5 
Log y’= 0.465 
Transformation back to original CoV %:  
y’= 100.465 
y’= 2.92 
An individual with a poor cognitive score on a measure of language (9) would be 
predicted to have a STV value of 7.57:  
Log y’= B1X1 + a 
Log y’= -0.069x + 1.5 
Log y’= -0.069(9) + 1.5 
Log y’= 0.879 
Transformation back to original CoV%:  
y’= 100.879 
y’= 7.57 
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Chapter 4: DISCUSSION 
4.1 General Discussion  
 
 The overall goal of this study was to evaluate the associations between a wide 
range of specific cognitive domains and quantitative gait variables during single and 
dual-task (DT) test conditions. All three hypotheses were confirmed at the conclusion of 
this study.  The present study has demonstrated that deficits in cognitive domains beyond 
executive function (EF) including memory and language are associated with quantitative 
gait measures. Previous studies have been limited in the measures of cognition evaluated, 
focusing almost exclusively on EF and attention, the present study has demonstrated that 
poor performance on tests evaluating working memory, episodic memory and language 
are also associated with DT declines in gait performance. This study has also 
demonstrated that measures of gait variability can be a more sensitive marker compared 
with mean values as It had a greaterr number of associations between cognitive domains 
when compared to mean values in individuals with mild cognitive impairment (MCI). 
Since DT conditions are used to assess shared cognitive resources during gait 
performance and stride-to-stride variations in gait are a reflection of dynamic gait 
regulation and stability, our results suggest that in our MCI sample gait regulation is 
indeed controlled by a number of higher level cognitive functions including resources 
from memory and language domains. Deficits in these cognitive domains may predispose 
an individual to gait abnormalities.  
 
 Our findings indicating deficits in memory and language were related to gait 
performance in addition to measures of EF and attention confirmed the first hypothesis. 
Of interest, DT test conditions were required to demonstrate additional relationships 
between deficits in language and memory domains and gait performance using 
quantitative gait measures.  To explain why aspects of gait would be affected by the 
addition of a secondary task and how gait would be related to tests of cognition through 
the capacity sharing DT theory provides a framework to explain why gait is affected…. 
This model states that information processing centers have limited mental resources 
shared among tasks and the processing capacity decreases with the addition of a 
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secondary task leading to a decrease in one or both tasks (Pashler, 1994; McLoed, 1977; 
Tombu & Jolicoeur, 2003). Age- related deterioration to physiological systems 
controlling and maintaining gait create a greater need to recruit higher level cognitive 
functions to properly integrate information necessary to regulate gait and dynamic 
stability (Hausdorff et al., 2005). Thus, DT changes in gait, especially those requiring 
involvement of multiple cognitive skills highlights the shared higher level neural 
networks between gait regulation and cognition.  
 
 As hypothesized, gait variability demonstrated in the linear regression analysis 
more associations between cognitive domains than mean gait variables in MCI. Of the 
four gait variability parameters, stride time variability (STV) was the most consistent gait 
parameter demonstrating associations among the most cognitive domains. Revisiting the 
original hypothesis proposed by Gabell & Nayak (1984), STV and stride length 
variability are considered a reflection of the automatic stepping mechanisms, controlled 
by the brainstem and basal ganglia (Rosano et al., 2007). These variables are considered 
highly dependent on cortical control and less affected by musculoskeletal performance 
(Beauchet et al., 2005; Montero-Odasso et al., 2012). Variability in step width and double 
support time are primarily determined by balance control mechanisms (Gabell & Nayak, 
1984). In the adjusted analysis, only the temporal parameter of double support time was 
associated with impairments in EF and attention during single task gait. The EF and 
attention cognitive tests used were timed, which may in part explain some of the 
associations found with temporal gait parameters. Meanwhile, both spatial and temporal 
gait variability parameters were able to detect associations between impairments in EF, 
attention, working memory and episodic memory during the same walking condition. 
These results suggest gait variability may be a better expression and more sensitive 
marker of the role of cortical resources during simple and dual gait tasks in MCI. 
 
 The significant declines in gait velocity and increases in gait variability while 
engaging in DT task activities found in our sample are consistent with previous research. 
The results adds further support to gait performance in healthy older adult and patient 
populations is less automatic and more dependant on cognitive control.  (Beauchet et al., 
71 
   
 
 
2005; Hausdorff et al., 2005; Hausdorff et al., 2008; Montero-Odasso et al., 2012; Muir et 
al., 2012; Sheridan et al., 2007; Woollacott & Shumway-Cook, 2002; Srygley, Mierlman, 
Herman, Giladi  & Hausdorff, 2009; van Iersel et al., 2008). The present findings are 
consistent with other reports demonstrating gait performance declined as DT test 
conditions increased in complexity (Montero-Odasso et al., 2012; Muir et al., 2012; 
Woollacott & Shumway-Cook, 2002). Increases in gait variability seen during DT test 
conditions reflects failure of automatic stepping and balance mechanisms (Nutt et al., 
1993), as a result of limited shared attentional capacities between cortical gait control and 
secondary cognitive tasks. Another possible explanation for the observed DT declines in 
gait could be a result of task  prioritization. When asked to perform walking and 
cognitive tasks concurrently, our population may inappropriately allocate attentional 
resources, sacrificing resources needed for stable gait by using a “posture second” 
strategy (Bloem et al., 2006).   
 
 Many researchers argue that gait is an over-learned automatic task requiring 
little or no higher level cognitive resources (Christensen et al., 2000; Fukuyama et al., 
1997). We found relationships between impairments in EF and memory with increases in 
gait variability even during single task gait. Our results are in part consistent with the 
results of Persaud et al. (1995) and Hausdorff et al. (2005) suggesting that routine 
walking can be considered a complex motor task requiring higher level cognitive input, 
especially in older adults.   
 
 EF is associated with areas in the frontal lobe, primarily the dorso-lateral 
prefrontal cortex and also plays an important role in older adults’ ability to divide 
attention (Sheridan et al., 2003; Woollcott & Shumway-cook, 2002; Yogev-Seligman et 
al., 2008). Executive dysfunction is considered a pervasive feature in AD (Sheridan et al., 
2003) and has been associated with increased fall risk in the elderly (Herman et al., 2010; 
Mierlman et al., 2012; Springer et al., 2006). Similar to other studies, we found 
associations between deficits in EF and attention with increases in gait variability during 
single and DT conditions (Ble et al., 2005; Hausdorff et al., 2005; Holtzer et al., 2012; 
Persaud et al., 1995; Sheridan, 2003). A probable explanation for finding associations 
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between EF, attention and gait performance is that EF may be a central component of the 
ability to divide attention and maintain safe gait and goal oriented walking control 
systems (Ble et al., 2005; Yogev-Seligmann et al., 2008). These findings may partially 
explain why increases in gait variability would be related to fall risk and also help explain 
why DT conditions would increase gait variability in those with EF dysfunction 
(Hausdorff et al., 2003; Sheridan et al., 2003). Additionally, deficits in EF have been 
suggested to predict gait impairments although no definitive relationship has been 
demonstrated (Yogev-Seligmann et al., 2008). Our results demonstrated that deficits in 
EF were associated with gait abnormalities expressed through increased variability in 
stride time and stride length during simple and DT walking.   
 
 We found associations with measures of working memory and increased 
double support time variability and step width variability. These findings are consistent 
with results from previous studies showing that difficulty maintaining balance was 
associated with atrophy in the parietal cortex (Rosano, Aizenstein, Studenski & Newman, 
2007; Rosano et al., 2008). It is possible that deficits in this cortical region may impair 
balance regulation and increased variability in these measures may be to compensate for 
these deficits (Rosano et al., 2008). 
 
 Hippocampal atrophy is related to memory impairments and is characteristic 
in MCI and AD (Du et al., 2001; Jack et al., 1999; Petersen, 2001). Studies have 
suggested the hippocampus also plays an essential role in locomotion through 
connections with the prefrontal cortex (Knight, 1996; Scherder et al., 2007; Song, Kim, 
Kim & Jung, 2005; Zimmerman et al., 2009). Studies identifying associations between 
memory deficits and decreased gait velocity (Holtzer et al., 2012; Mielke et al., 2013; 
Montero-Odasso et al., 2009; Verghese et al, 2007; Watson et. al, 2010), as well as gait 
variability (Hausdorff et al., 2008) were consistent with our results. We found 
associations between deficits in episodic memory and increased in variability in stride 
time and double support time during DT circumstances. Conversely, a number of studies 
have found no associations with memory function and gait disturbances (Hausdorff et al., 
2005; Herman et al., 2010; Holtzer et al., 2006; Mierlman et al., 2012; Persaud et al., 
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2008 Springer et al., 2006; van Iersel et al., 2008). Safe and stable locomotion through an 
environment relies on the integration of visual, vestibular and proprioceptive information 
(Hausdorff et al., 2008). The hippocampus is involved with all of these functions and 
shares close neural connections with the prefrontal cortex, an area involved with EF 
(Malouin et al., 2003). Thus, our results support the idea that memory retrieval and 
encoding in the hippocampus uses shared networks as those which maintain dynamic gait 
and stability, particularly in challenging or unfamiliar environments.  
 
 Additionally, previous studies have found that working and episodic memory 
are the first functions compromised in AD (Aggarwal et al., 2005; Petersen et al., 2001). 
A recent study showed that deficits in working memory can be a marker of progression to 
dementia in people with MCI (Missonnier et al., 2005) and other studies have shown that 
the presence and severity of episodic memory deficits in MCI was more robustly related 
to risk of AD than impairment in other domains (Aggarwal et al., 2005; Jack et al., 1999). 
The results from this study support future research on the prognostic utility of the 
associations found in predicting those who at high risk for progression to dementia.  
 
As described previously, the cortical and sub-cortical control of gait is not 
well understood. Neuro-imaging studies have shown increased gait variability (i.e., stride 
time, stride length) and poor balance are primarily related to deficits in the frontal and 
temporal lobes, white matter abnormalities, brain infarcts and basal ganglia dysfunction 
(Guo et al., 2001; Malouin et al., 2003; Rosano et al. 2007; Rosano et al., 2008; Rosano 
et al., 2012). Areas such as the hippocampus and parietal lobe are also showing 
associations with motor control and gait stability (Malouin et al., 2003; Rosano et al., 
2008; Zimmerman et al., 2009). The increased stride time and stride length variability 
observed in the present study could represent subtle mobility impairments related to early 
dysfunction of these cortical and sub-cortical areas regulating gait (Rosano et al., 2007). 
This is supported by studies which suggest gait impairments precede cognitive 
impairments (Mielke et al, 2013; Montero-Odasso et al., 2012; Buracchino et al., 2010; 
Verghese et al., 2007).  
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 Of note, STV was also the only gait parameter to detect associations in the 
language domain during naming animal’s gait testing. Faster gait speed has been found to 
be protective of language deficits (Mielke et al., 2013) however; to our knowledge this is 
the first study to demonstrate associations between deficits in the language domain and 
increased stride-to-stride variability. Language deficits often extend beyond Wernicke’s 
and Broca’s area to include other areas of the temporal lobe as well as areas in the 
parietal lobe (Hart & Gordon, 1990; McCroy, Firth, Brunswick & Price, 2000; Price et 
al., 1996; Wise et al., 1991). Thus, complete language comprehension and speech 
production involves additional areas outside of the temporal and prefrontal cortex. This 
suggests that increased STV may not only be a marker of deficits in EF and attention but 
also sensitive to detect deficits in other areas of the brain not typically known to be 
associated with gait control.  Furthermore, these associations suggest that at least while 
walking and completing a secondary task requiring verbal fluency, there is a shared 
neural network among areas in the brain which control communication and language and 
areas that control gait stability.  
 
 Lack of associations found between gait and the language domain may be 
because our sample did not demonstrate deficits below normal values in this cognitive 
domain. Additionally, several studies have demonstrated that EF and attention 
impairments are the first non-memory domains affected in cognitive decline which 
usually occur before language impairments (Binetti et al., 1996; Lafleche & Albert, 1995; 
Reid et al., 1996). Lack of associations found may also be due to the insensitivity of the 
Boston Naming Test (15-item) in detecting language deficits. The test may not be 
challenging enough to detect aphasia. A more sensitive measure of deficits in language 
such as the full 60-item version of the Boston Naming Test may provide enough 
sensitivity to detect additional associations and should be further explored.  
 
 In summary, previous research has clearly demonstrated EF and attention are 
required for gait. We expand on this literature by demonstrating multi-tasking through an 
environment requires not only the higher level cognitive functions of EF and attention but 
also utilizes cognitive input from memory and language neural systems. In our analysis 
75 
   
 
 
we found relationships between deficits in several cognitive domains associated with the 
cortical areas involved in gait control. These findings are consistent with complex neural 
correlates for gait control believed to incorporate frontal, temporal and parietal cortical 
circuits and in addition to sub-cortical structures of the basal ganglia and brainstem (Guo 
et al., 2001; Malouin et al., 2003; Scherder et al., 2007; Sheridan & Hausdorff, 2007; 
Watson et al., 2010).  
 
4.2 Strengths and Limitations  
 
 This study has the strengths of using a comprehensive evaluation of spatial 
and temporal gait variables in a well-defined population meeting the strict criteria for 
MCI. All MCI participants were identified by the same validated clinical criteria 
(Petersen, 2004; Winblad, 2004). This study also used a detailed and wide range of 
neuropsychological assessments to appropriately categorize the specific cognitive 
domains of executive function, memory, attention and language. The neuropsychological 
and gait assessments are well established and validated in samples for MCI (Montero-
Odasso et al, 2009; Montero-Odasso et al., 2012). Few studies evaluating the relationship 
between gait and cognition in an MCI population use the DT paradigm. The present study 
makes use of multiple conditions of DT to assess the associations. 
 
 Some limitations need to be outlined. The cross-sectional design precludes us 
to infer causality or confirm the temporal order of the relationship between gait 
performance and cognitive measures. The sample size in the current study was relatively 
small and may have not been large enough to detect weaker associations and as a result 
some associations may have been missed. Despite this, to our knowledge this is the 
largest sample size assessing MCI older adults using DT gait conditions. Our findings 
need to be replicated and further investigated in longitudinal studies with larger sample 
sizes. This limitation creates biases towards the null hypothesis. Another limitation was 
the risk of type I error (asserting associations are true when they are not) due to 
evaluation of a large number of variables increases the chances of deeming a true non-
significant associations significant. The Bonferroni test in post-hoc ANOVA analysis was 
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used to handle multiple testing conditions. Another area of concern would be the use of a 
short walkway and the number of strides collected. While the number of strides required 
to measure stride-to-stride variability is unknown, previous research has indicated that 
limited stride numbers can influence the reliability of the measures (Brach et al., 2008). 
Even with a short walkway we were still able to detect effects of DT testing and 
associations between the individual cognitive domains and gait performance suggesting 
study values are likely sufficient. It should be noted, dual-tasking over a long walkway is 
not ideal because an individual may not be able to sustain tasks over an extended period 
of time (Lord et al., 2011). The lack of associations found in this study may be due to 
limited number of gait data points. Future studies would be beneficial to evaluate these 
associations with a larger number of strides in a larger population. However, there may 
be trade-off issues between a need to collect more data and to limit participant burden 
that doesn’t have an easy solution. Although the study used a large number of 
neuropsychological tests, episodic memory was assessed only with verbal tests. It is 
unknown whether the results from this test can be applied to episodic memory for non-
verbal information as well. Thus, a more inclusive evaluation of episodic memory is 
warranted. Another potential limitation is that this study did not account for errors during 
dual tasking conditions; consequently the sincerity and accuracy during DT conditions 
could not be determined. The lack of associations found in the current study during serial 
7 subtractions gait could be a result of our inability to determine and account for an 
individual’s genuine effort while performing this DT test. For example, an individual 
may not have been able to perform serial 7 subtractions as a single task and during the 
DT condition their gait performance may be closer to a single task. This limitation biases 
our results towards the null hypothesis. Across the literature there are currently 
inconsistencies concerning how to handle errors and effort among DT conditions 
correctly but, in the future it would be better to evaluate the secondary task as a single 
task activity.  
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4.3 Future Directions 
 
 In line with previous research, our results highlight the importance of DT 
testing and gait variability in clinical settings. Future studies should focus on determining 
the temporal order of this relationship as this has the potential to determine whether gait 
variability can be used as a predictor for cognitive decline and progression to dementia. 
Differences in measures of mean, variance and quantity for gait performance are not 
consistent across the literature. Additionally, definitions of specific cognitive domains 
across the literature are not always uniform (Segev- Jacubovski et al., 2011). Future 
studies should focus on establishing standardized reference values for gait variables and 
refining descriptions of cognitive domains in order to understand differences across all 
parameters and enhance clinical interpretations. Typically gait and cognitive function are 
studied as distinct entities as a result neuropsychological tests are not integrated in 
routine assessments of mobility decline and fall risk. The findings of the present study 
suggest future studies should focus efforts to include cognitive measures in the traditional 
approaches to mitigate fall risk and determining the effects of cognitive training in 
cognitive domains such as memory and language will be able to improve gait. Cognitive 
training has also been shown to improve cognition in some older adult populations (Ball 
et al., 2002; Peretz et al., 2011; Willis et al., 2006). It would be of interest to further 
investigate the effects of training specific cognitive domains on gait characteristics. 
Lastly, future studies should corroborate findings with neuro-imaging results to help 
assess the anatomical and neural correlates between motor and cognitive functions. Gait 
variability is vital to the understanding of interactions underlying the cognitive control of 
gait; therefore, DT changes in gait variability can potentially serve as a clinical tool for 
targeting cognitively impaired older adults at risk for mobility and further cognitive 
decline.  
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Chapter 5: CONCLUSION 
 
 Walking is not automatic and emerging evidence shows that gait control relies 
on cortical processes; however, the exact mechanisms controlling gait are not completely 
understood. This study demonstrated that deficits in memory and language, which are 
beyond executive function (EF), are associated with poor to gait performance, more 
specifically gait variability measures. Decreases in various cognitive abilities were 
associated with poorer performance on gait variability measures.  
 
 Our findings suggest that gait variability is a sensitive marker for cognitive 
function because was associated with cognitive deficits while spatial and temporal gait 
parameters failed to do so. Gait variability is an expression of the cortical control on gait 
(Montero-Odasso et al., 2011; Beauchet et al., 2012) and detrimental gait changes in 
stride-to-stride variability observed while dual-tasking can not only identify cognitively 
impaired older adults at risk for gait disorders and falls, but could also represent the 
extent of the cognitive reserve. Thus, increased gait variability during dual-tasking may 
reflect subtle gait disturbances related to early stages of cortical and sub-cortical 
dysfunction. 
 
 Furthermore, we demonstrate the benefits of incorporating DT gait conditions 
as an appropriate tool to detect interactions and provide pertinent information concerning 
the relationship between motor control and specific cognitive functions. Since the 
magnitudes of the changes of dual-task gait variability are more related to cognitive 
deficits in our MCI population, we postulate that gait changes seen while dual tasking can 
be used as a biomarker of cognitive impairment and potentially help to better characterize 
those individuals who may progress to further cognitive decline and future dementia 
(Waite et al., 2005, Montero-Odasso et al. 2014). The combination of neuropsychological 
and gait assessments can provide the clinician with important information about multiple 
adverse events which otherwise would not be detected during a routine exam (Yogev-
Seligman et al., 2008).  Finally, the gait reduction seen in our study while dual tasking 
provides evidence that complex cognitive challenge in high function older individuals 
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with cognitive impairment pose them at risk of mobility decline at fall since their mean 
velocity decreased below the accepted threshold for fall risk ( below 100 cm/s). This 
potential clinical added value of dual-task gait in the cognitive impaired can be tested in 
future longitudinal studies. 
 
 In summary, gait control is clearly multi-factorial and this study provides 
evidence to support gait as a complex motor function,  its control shares similar 
underlying neural substrate with specific cognitive domains. Improved understanding of 
the relationship between gait and cognitive impairments can help identify older adults at 
higher risk for mobility decline, falls and progression to dementia.  
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Appendix B: 
 Normal Distributions and Log transformed distributions for gait variability 
parameters  
Single task gait variability parameters:  
Untransformed Distributions Log Transformed Distributions 
Stride Time: 
 
Stride Time: 
 
Stride Length: 
 
Stride Length: 
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Double Support Time: 
 
Double Support Time:  
 
Step Width:  
 
Step Width: 
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Counting backwards by 1’s gait variability parameters:  
Untransformed Distributions Log Transformed Distributions 
Stride Time: 
 
Stride Time: 
 
Stride Length:  
 
Stride Length: 
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Double Support Time: 
 
Double Support Time:  
 
Step Width: 
 
Step Width: 
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Naming animals gait variability parameters:  
Untransformed Distributions Transformed Log Distributions 
Stride Time: 
 
Stride Time: 
 
Stride Length:  
 
Stride Length: 
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Double Support Time:  
 
Double Support Time: 
 
Step Width:  
 
 
Step Width: 
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Serial seven subtraction gait variability: 
Untransformed Distributions Log Transformed Distributions 
Stride Time:  
 
Stride Time: 
 
Stride Length: Stride Length: 
 
111 
   
 
 
 
Double Support Time:  
 
Double Support Time: 
 
Step Width: 
 
Step Width: 
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Appendix C:  
Results from the unadjusted linear regression analysis comparing the associations of individual cognitive domains on an outcome 
of gait variables during single task and dual task walking conditions  
Table D.1: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variables during usual 
gait 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during usual gait:  
Velocity (cm/s) Stride Time (ms) Stride Length (cm) Double Support Time 
(sec) 
Step Width (cm) 
TMT A  -0.29 (-0.614, 0.016) 
p= .062 
1.07 (-.380, 2.51) 
p= .146 
-0.212 (-.50, .077) 
p= .147 
1.31 (0.245, 2.37)  
p= .017 
-0.098 (-0.243, 0.047)  
p= .181 
∆TMT -0.031 (-0.106,0 .045) 
p= .418 
0.130 (-0.214, 0.474) 
p= .453 
-0.0018 (-0.087, 0.050) 
p= .597 
0.272 (0.020, 0.524) 
p= .035 
-0.018 (-0.052, 0.016) 
p= .302 
DST-B 0.67 (-1.6, 3.0) 
p= .563 
-3.35 (-13.77, 7.07) 
p= .523 
0.407 (-1.68, 2.49) 
p= .698 
-4.03 (-11.85, 3.80)  
p= .308 
0.163 (-0.905, 1.23) 
p= .762 
∆DST  -2.2 (-4.5, 0.12) 
p= .063 
10.41 (-0.182, 21.02) 
p= .054 
-1.29 (-3.44, 0.867) 
p= .237 
5.12 (-3.01, 13.25) 
p= .213 
-1.02 (-2.08, 0.050) 
p= .061 
LNS 0.69 (-1.35, 2.73) 
p= .501 
.919 (-8.40, 10.24) 
p= .845 
0.892 (-0.954, 3.74) 
p= .338 
-2.35 (-9.36, 4.67) 
p= .507 
0.344 (-0.598, 1.29) 
p= .468 
RAVLT  0.27 (-1.6, 2.12) 
p= .767 
-5.83 (-14.11, 2.44) 
p= .164 
-0.246 (-1.92, 1.43) 
p= .770 
-3.91 (-10.18, 2.35) 
p= .217 
-0.004 (-0.838, -0.829) 
p= .992 
BNT  2.72 (-1.18, 6.63) 
p= .169 
-0.011 (-18.09, 18.07) 
p= .999 
3.45 (-0.055, 6.95) 
p= .054  
-12.79 (-26.07, 0.485) 
p= .059 
1.69 (-0.079, 3.46) 
p= .061 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table D.2: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variables 
during counting by 1’s gait  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during counting by 1’s gait:  
Velocity (cm/s) Stride Time (ms) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.441 (-.811, -.072) 
p= .020 
2.52 (0.330, 4.72) 
p= .025 
-0.243 (-0.570, 0.085)  
p= .144 
0.721 (-0.55, 2.0) 
p= .263 
-0.11 (-0.26, 0.041) 
p=.150 
∆TMT -0.061 (-0.151, 0.028) 
p=.174 
0.425 (-0.100, 0.950) 
p= .111 
-0.025 (-0.103, 0.053) 
p= .520 
0.283 (-0.010, 0.577) 
p= .058 
-0.013 (-0.049, 0.023) 
p= .485 
DST-B 2.08 (-0.608, 4.76) 
p= .127 
-15.04 (-30.80, 0.717) 
p=.061 
0.780 (-1.58, 3.14) 
p= .511 
-5.14 (-14.18, 3.90) 
p= .261 
-0.016 (-1.14, 1.11) 
p= .978 
∆DST  -3.82 (-6.52, -1.13) 
p= .006 
25.44 (9.75, 41.13) 
p= .002 
-1.86 (-4.29, 0.560) 
p= .130 
12.32 (3.29, 21.35) 
p= .008 
-0.99 (-2.12, 0.146) 
p= .086 
LNS 1.21 (-1.20, 3.64) 
p= .318 
-3.21 (-17.63, 11.21) 
p= .658 
1.08 (-1.01, 3.17) 
p= .308 
-1.59 (-9.72, 6.55) 
p= .698 
0.208 (-0.789, 1.20) 
p= .678 
RAVLT  0.579 (-1.61, 2.77)  
p= .600 
-10.43 (-23.19, 2.32) 
p= .107 
-0.147 (-2.05, 1.75) 
p= .878 
-7.43 (-14.54, -0.330) 
p= .041 
-0.111 (-0.990, 0.767) 
p= .801 
BNT  3.86 (-0.77, 8.49) 
p= .101 
-9.93 (-37.82, 17.95) 
p= .479 
4.11 (0.152, 8.07) 
p= .042 
-13.82 (-29.23, 1.6) 
p= .078 
1.33 (-0.557, 3.22) 
p= .164 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table D.3: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variables 
during naming animals gait  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during naming animal’s gait:  
Velocity (cm/s) Stride Time (ms) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.33 (0.73, 0.077) 
p= .111 
3.03 (-.145, 6.2) 
p= .061 
-0.167 (-0.54, 0.208) 
p= .377 
1.23 (-0.85, 3.28) 
p= .244 
-0.11 (-0.28, 0.059) 
p= .197 
∆TMT  -0.047 (-0.142, 0.048) 
p= .329 
0.48 (-0.28, 1.23) 
p=.207 
-0.008 (-0.096, 0.079) 
p= .849 
0.33 (-0.14, 0.81) 
p= .168 
-0.011 (-0.051, 0.029) 
p= .573 
DST-B 1.53 (-1.35, 4.41) 
p= .292 
-5.59 (-28.54, 17.36) 
p= .628 
0.98 (-1.67, 3.64) 
p= .461 
-2.0 (-16.73, 12.73) 
p= .787 
0.34 (-0.90, 1.58) 
p= .586 
∆DST  -4.39 (-7.18, -1.52) 
p= .003 
25.97 (2.86, 49.08) 
p= .028 
-2.86 (-5.56, -0.177) 
p= .037 
15.73 (0.850, 30.61) 
p= .039 
-0.18 (-2.66, 2.31) 
p= .888 
LNS 0.590 (-2.04, 3.22) 
p= .656 
-2.72 (-23.62, 18.18) 
p= .796 
0.73 (-1.69, 3.15) 
p= .548 
-1.62 (-15.02, 11.78) 
p=.810 
0.23 (-0.87, 1.33) 
p= .676 
RAVLT  0.407 (-1.91, 2.72) 
p= .727 
-12.36 (-30.46, 5.75) 
p= .178 
-0.323 (-2.45, 1.80) 
p= .762 
-9.45 (-20.99, 2.08) 
p= .107 
-0.049 (-1.02, 0.921) 
p= .920 
BNT  2.51 (-2.44, 7.46) 
p= .316 
-13.39 (-52.81, 26.03) 
p= .500 
3.26 (-1.25, 7.77) 
p= .154 
-24.89 (-49.49, -0.29) 
p= .047 
1.23 (-0.86, 3.33) 
p= .242 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table D.4: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variables 
during serial seven’s gait.  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variables during serial seven’s gait:  
Velocity (cm/s) Stride Time (ms) Stride Length (cm) Double Support 
Time (sec) 
Step Width (cm) 
TMT A  -0.42 (-0.840, 0.001) 
p= .050 
3.38 (-2.30, 9.01) 
p= .239 
-0.23 (-0.59, 0.12)  
p= .193 
0.96 (-1.05, 2.97) 
p= .342 
-0.13 (-0.30, 0.036) 
p= .122 
∆TMT  -0.070 (-0.170, 0.031) 
p= .171 
0.62 (-0.72, 2.0) 
p= .360 
-0.025 (-0.109, 0.058) 
p= .548 
.375 (-0.089, 0.840)  
p= .112 
-0.020 (-0.059, 
0.020) 
p= .331 
DST-B 1.72 (-1.33, 4.76) 
p= .265 
-16.07 (-56.59, 24.45) 
p= .431 
0.939 (-1.59, 3.47) 
p= .460 
-2.39 (-16.72, 11.94) 
p= .740 
0.33 (-0.92, 1.58) 
p= .601 
∆DST  -5.12 (-8.07, -2.17) 
p= .001 
55.83 (15.63, 96.03) 
p= .007 
-3.02 (-5.56, -.480) 
p= .021 
23.56 (9.77, 37.35) 
p= .001 
-1.73 (2.94, -0.53) 
p= .006 
LNS 0.73 (-2.01, 3.46) 
p= .597 
-6.51 (-42.79, 29.77) 
p= .721 
0.92 (-1.34, 3.17) 
p= .420 
-0.68 (-13.47, 12.11) 
p= .916 
0.43 (-0.67, 1.53) 
p= .435 
RAVLT  -0.25 (-2.72, 2.22) 
p= .840 
11.95 (-20.63, 44.53) 
p= .467 
-0.44 (-2.47, 1.60) 
p= .670 
-2.40 (-13.90, 9.11) 
p= .679 
-0.015 (-0.99, 0.96) 
p= .975 
BNT  -2.07 (-3.44, 7.16) 
p= .486 
6.58 (-63.81, 76.96) 
p= .853 
2.75 (-1.59, 7.08)  
p= .210 
-8.76 (-33.46, 15.94) 
p= .481 
1.25 (-0.86, 3.35) 
p= .241 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Appendix D:  
Results from the unadjusted linear regression analysis comparing the associations of individual cognitive domains on 
an outcome of gait variability during single and dual task walking conditions  
Table E.1: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variability 
during single task gait. 
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during single task gait (log):  
Stride Time (ms) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.0087 (-0.003, 0.003) 
p= .953 
0.001 (-0.004, 0.006) 
p= .611 
0.00 (-0.004, 0.003) 
p= .844 
-0.001 (-0.004, 0.003) 
p= .704 
∆TMT 0.001 (0.00- 0.001) 
p= .062  
0.001 (0.00, 0.002) 
p= .024 
0.001 (0.00, 0.002) 
p= .064 
0.00 (0.00, 0.001) 
p= .217 
DST-B -0.014 (-0.034, 0.006) 
p= .174 
-0.021 (-0.054, 0.013)  
p= .224 
0.00 (-0.026, 0.026) 
p= .978 
-0.003 (-0.028, 0.022) 
p= .803 
∆DST  0.005 (-0.017, 0.26) 
p= .664 
0.017 (-0.019, 0.052) 
p= .354 
-0.004 (-0.031, 0.023) 
p= .748 
0.008 (-0.017, 0.033) 
p= .536 
LNS -0.027 (-0.044, 0.010) 
p= .003 
-0.041 (-0.070, 0.012) 
p= .006 
-0.021 (-0.044, 0.001) 
p= .064 
-0.013 (-0.035, 0.008) 
p= .217 
RAVLT  -0.013 (-0.029, 0.004) 
p= .127 
-0.025 (-0.051, 0.002) 
p= .070 
0.012 (-0.008, 0.033) 
p= .243 
-0.018 (-0.037, 0.001) 
p= .061 
BNT  0.00 (-0.036, 0.036) 
p= .994 
-0.011 (-0.070, 0.047) 
p= .699 
-0.035 (-0.079, 0.009) 
p= .121 
-0.003 (-0.045, 0.039) 
p= .884 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table E.2: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variability 
during counting by 1’s gait  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during counting by 1’s gait (log): 
Stride Time (ms) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.003 (0.00, 0.006) 
p= .049 
0.007 (0.003, 0.011)  
p= .001 
0.001 (-0.002, 0.004) 
p= .342 
0.003 (0.00, 0.005) 
p= .080 
∆TMT 0.001 (0.00, 0.002) 
p= .008 
0.001 (0.00, 0.002) 
p= .104 
0.00 (0.00, 0.001) 
p= .183 
0.00 (0.00, 0.001) 
p= .318 
DST-B -0.022 (-0.045, 0.001) 
p= .060 
-0.028 (-0.057, 0.001) 
p= .062 
-0.015 (-0.037, 0.006) 
p= .157 
-0.007 (-0.028, 0.014) 
p= .491 
∆DST  0.028 (0.004, 0.052) 
p= .020 
0.024 (-0.006, 0.055) 
p= .119 
0.008 (-0.015, 0.030) 
p= .500 
0.009 (-0.013, 0.031) 
p= .404 
LNS -0.012 (-0.033, 0.009) 
p= .243 
-0.033 (-0.059, -0.008) 
p= .011 
-0.023 (-0.042, -0.005) 
p= .014 
-0.010 (-0.028, 0.009) 
p= .293 
RAVLT  -0.020 (-0.038, -0.002) 
p=.033 
-0.016 (-0.040, 0.008) 
p= .184 
-0.020 (-0.037, -0.003) 
p= .021 
-0.013 (-0.029, 0.003) 
p= .104 
BNT  -0.026 (-0.066, 0.014) 
p= .203 
0.036 (-0.087, -0.015) 
p= .167 
-0.020 (-0.058, 0.017) 
p= .281 
-0.004 (-0.040, 0.032) 
p= .807 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table E.3: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variability 
during naming animal’s gait  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during naming animals gait (log): 
Stride Time (ms) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.006 (0.002, 0.010) 
p= .006 
0.003 (-0.001, .007) 
p= .090 
0.00034 (-0.003, 0.003) 
p= .984 
0.002 (-0.001, 0.006) 
p= .173 
∆TMT  0.001 (0.00, 0.002) 
p= .062 
0.00 (-0.001, .001) 
p= .628 
0.00 (-0.001, 0.001) 
p= .502 
0.00 (0.00, 0.001) 
p= .293 
DST-B -0.019 (-0.049, 0.011) 
p= .217 
-0.031 (-0.058, -.003) 
p= .029 
-0.006 (-0.030, 0.018) 
p= .623 
-0.021 (-0.046, 0.003) 
p= .089 
∆DST  0.030 (0.00, 0.061) 
p= .053 
0.043 (0.015, 0.070) 
p= .003 
0.009 (-0.017, 0.034) 
p= .499 
0.043 (0.020, 0.066) 
p<.001 
LNS -0.026 (-0.053, 0.00) 
p= .052 
-0.019 (-0.045, 0.006) 
p= .135 
-0.002 (-0.024, 0.019)  
p= .823 
-0.009 (-0.031, 0.013) 
p= .437 
RAVLT  -0.005 (-0.029, 0.019) 
p= .680 
-0.012 (-0.035, 0.010) 
p= .271 
0.004 (-0.015, 0.023) 
p= .681 
-0.013 (-0.032, 0.006) 
p= .182 
BNT  -0.068 (-0.117, -0.019) 
p= .007 
-0.038 (-0.086, 0.010) 
p= .123 
-0.015 (-0.056, 0.026) 
p= .463 
-0.027 (-0.069, 0.015) 
p= .210 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05. 
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Table E.4: Unadjusted linear regression comparing the association of cognitive test scores on an outcome of gait variability 
during serial sevens gait  
Unstandardized Regression Coefficients, (95% CI) 
 Gait Variability during serial sevens gait (log):  
Stride Time (ms) Stride Length (cm) Double Support Time (sec) Step Width (cm) 
TMT A  0.003 (-0.001, 0.007) 
p= .180 
0.002 (-0.003, 0.006) 
p= .423 
-0.001 (-0.005, 0.003) 
p= .566 
0.001 (-0.003, 0.005) 
p= .502 
∆TMT  0.001 (0.00, 0.002) 
p= .265 
0.00 (-0.001, 0.001) 
p= .683 
0.00 (-0.001, 0.001) 
p= .596 
0.00 (-0.001, 0.001) 
p= .571 
DST-B -0.005 (-0.036, 0.027) 
p= .765 
-0.025 (-0.057, 0.006) 
p= .110 
0.011 (-0.016, 0.038) 
p= .415 
-0.009 (-0.037, 0.019) 
p= .512 
∆DST  0.033 (0.001, 0.065) 
p= .041 
0.037 (0.005, 0.069) 
p= .024 
0.012 (-0.015, 0.040) 
p= .378 
0.022 (-0.006, 0.050) 
p= .117 
LNS -0.009 (-0.037, 0.020) 
p= .547 
-0.019 (-0.047, 0.009) 
p= .182 
0.007 (-0.017, 0.031) 
p= .550 
-0.007 (-0.032, 0.018) 
p= .565 
RAVLT  0.017 (-0.008, 0.042) 
p= .190 
-0.006 (-0.031, 0.020) 
p= .656 
0.010 (-0.012, 0.031) 
p= .372 
-0.006 (-0.028, 0.016) 
p= .591 
BNT  -0.022 (-0.076, 0.033) 
p= .426 
0.030 (-0.025, 0.084) 
p= .282 
0.033 (-0.013, 0.079) 
p= .154 
0.031 (-0.016, 0.078) 
p= .188 
 
Notes: Analysis adjusted for age, body mass index, total number of medications and total number of co-morbidities; 
TMT=Trail Making Test, DST-B=Digit Span Test Backwards, LNS= Letter Number Sequencing, RAVLT= Rey Auditory 
Verbal Learning Test, BNT= Boston Naming Test, ∆=delta, bold values are statistically significance at p<0.05.
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